<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.67.04/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.67.04/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|67|04|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="04"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|67|04" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.67.04"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.67.04/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.67.04/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|67" data-search-heading="">
                  <a href="/us/md/exec/comar/10.67" title="Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM">Subtitle 67 MARYLAND HEALTHCHOICE PROGRAM</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|67|04" data-search-heading="">
                  <span title="Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations">Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|67|04">
              <div class="tuf-authenticate">
                <h1 class="h__title--small" id="/us/md/exec/comar/10.67.04">Chapter 04 Maryland Medicaid Managed Care Program: Managed Care Organizations</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23" title=".23 Marketing.">.23</a> adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23" title=".23 Marketing.">.23</a> adopted effective March 10, 1997 (24:5 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">Regulation .01</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p>Regulations .02C, .04C, .08, .11, .15, .17A, .18, .20B, and .22C amended and Regulation .11-1 adopted as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended effective February 9, 1998 (25:3 Md. R. 144); November 1, 1999 (26:22 Md. R. 1692); February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a> and H amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulation .03P amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulation .03T adopted effective February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03" title=".03 Quality Assessment and Improvement.">Regulation .03</a> repealed and new Regulation .03 adopted effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04#C" title="">Regulation .04C</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05" title=".05 Special Needs Populations — Children with Special Health Care Needs.">Regulation .05</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05" title=".05 Special Needs Populations — Children with Special Health Care Needs.">Regulation .05</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#K" title="">Regulation .05K</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08" title=".08 Special Needs Populations — Pregnant and Postpartum Women.">Regulation .08</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08" title=".08 Special Needs Populations — Pregnant and Postpartum Women.">Regulation .08</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#B" title="">Regulation .10B</a> amended effective February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended as an emergency provision effective July 1, 2000 (27:15 Md. R. 1397); amended permanently effective October 16, 2000 (27:20 Md. 1838)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> amended effective February 18, 2002 (29:3 Md. R.220); December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .11-1 and .11-2 adopted February 9, 1998 (25:3 Md. R. 144)</p>
                  <p>Regulation .11-1 and .11-2E amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p>Regulations .11-1 and .11-2 amended as an emergency provision effective July 1, 2000 (27:15 Md. R. 1397); amended permanently effective October 16, 2000 (27:20 Md. R. 1838)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15" title=".15 Data Collection and Reporting.">Regulation .15</a> amended effective February 9, 1998 (25:3 Md. R. 144); December 25, 2000 (27:25 Md. R. 2281); February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#B" title="">Regulation .15B</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D" title="">Regulation .15D</a>, E amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.16" title=".16 Repealed.">Regulation .16</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#A" title="">Regulation .17A</a> amended effective February 9, 1998 (25:3 Md. R. 144); December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B" title="">Regulation .17B</a> amended effective February 18, 2002 (29:3 Md. R.220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">Regulation .18</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18-1" title=".18-1 MCO Reimbursement — GME Exclusion.">Regulation .18-1</a> adopted as an emergency provision effective April 7, 1998 (25:9 Md. R. 676); adopted permanently effective June 29, 1998 (25:13 Md. R. 993)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18-1" title=".18-1 MCO Reimbursement — GME Exclusion.">Regulation .18-1</a> amended effective December 25, 2000 (27:25 Md. R.2281)</p>
                  <p>Regulation .18-1C adopted effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); emergency status extended at 26:1 Md. R. 17, 26:6 Md. R. 480, and 26:8 Md. R. 614; emergency status expired May 1, 1999</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective May 1, 1999 (26:9 Md. R. 727 and 26:10 Md. R. 794); emergency status expired November 1, 1999</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective December 25, 2000 (27:25 Md. R.2281)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#A" title="">Regulation .19A</a> amended as an emergency provision effective March 31, 2001 (28:7 Md. R. 685); emergency status extended at 28:22 Md. R. 1931 and 29:4 Md. R. 413</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">.19-1</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">.19-3</a> adopted as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">.19-1</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-4" title=".19-4 MCO Medical Loss Ratio.">.19-4</a> adopted effective December 25, 2000 (27:25 Md. R. 2281)</p>
                  <p>Regulations .19-1 and .19-2 repealed and new Regulation .19-1 adopted effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">Regulation .19-1</a> repealed as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); repealed permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p>Regulations .19-3 and .19-4 amended and recodified to be new Regulations .19-2 and .19-3 effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended as an emergency provision effective July 1, 2002 (29:15 Md. R. 1139); amended permanently effective October 28, 2002 (29:21 Md. R. 1645)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-4" title=".19-4 MCO Medical Loss Ratio.">Regulation .19-4</a> adopted effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulations .19-5 and.19-6 adopted as an emergency provision effective March 31, 2001 (28:7 Md. R. 685); emergency status extended at 28:22 Md. R. 1931; emergency status extended at 29:4 Md. R. 413</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20</a> amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); amended permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20</a> amended as an emergency provision effective July 1, 2003 (30:21 Md. R. 1527); amended permanently effective November 10, 2003 (30:22 Md. R. 1580)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a> amended effective December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#B" title="">Regulation .20B</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">Regulation .21</a> amended effective December 25, 2000 (27:25 Md. R. 2281); December 24, 2001 (28:25 Md. R. 2190); July 7, 2003 (30:13 Md. R. 854)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective May 1, 1999 (26:9 Md. R. 727 and 26:10 Md. R. 794); emergency status expired November 1, 1999</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; adopted permanently effective June 25, 2001 (28:12 Md. R. 1109)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended effective December 24, 2001 (28:25 Md. R. 2190)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22#A" title="">Regulation .22A</a> amended and F—J adopted effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22#C" title="">Regulation .22C</a> amended effective February 9, 1998 (25:3 Md. R. 144)</p>
                  <p>Regulations .24 and .25 adopted as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261); adopted permanently effective January 1, 1999 (25:26 Md. R. 1925)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> amended as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 25, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> amended effective December 25, 2000 (27:25 Md. R.2281); December 23, 2002 (29:25 Md. R. 1981)</p>
                  <p>Regulation .24-1 adopted as an emergency provision effective December 1, 1999 (26:25 Md. R. 1888); emergency status expired December 31, 2000</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.26" title=".26 Time Period for Termination of Provider Agreement.">Regulation .26</a> adopted effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.27" title=".27 Newborn Coordinator.">Regulation .27</a> adopted effective February 18, 2002 (29:3 Md. R. 220)</p>
                  <p>——————</p>
                  <p>Chapter revised effective February 2, 2004 (31:2 Md. R. 82)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.01" title=".01 Incorporation by Reference — Repealed">Regulation .01</a> repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .01B amended effective December 27, 2010 (37:26 Md. R. 1787)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02" title=".02 Conditions for Participation.">Regulation .02</a> amended effective June 30, 2008 (35:13 Md. R. 1180); April 28, 2014 (41:8 Md. R. 471); February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#G" title="">Regulation .02G</a>, J, X amended effective November 7, 2016 (43:22 Md. R. 1221)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#K" title="">Regulation .02K</a> amended effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#O" title="">Regulation .02O</a>, S amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>Regulation .02V amended effective December 27, 2010 (37:26 Md. R. 1787)</p>
                  <p>Regulation .02Z adopted effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#C" title="">Regulation .02C</a>C amended effective October 5, 2009 (36:20 Md. R. 1528); March 14, 2016 (43:5 Md. R. 385)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#D" title="">Regulation .02D</a>D adopted effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#E" title="">Regulation .02E</a>E adopted effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#K" title="">Regulation .02K</a>, L amended effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.02#F" title="">Regulation .02F</a>F adopted effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03" title=".03 Quality Assessment and Improvement.">Regulation .03</a> amended effective February 12, 2018 (45:3 Md. R. 156)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#A" title="">Regulation .03A</a>, B amended effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended effective December 19, 2005 (32:25 Md. R. 1941); April 9, 2007 (34:7 Md. R. 698); November 5, 2007 (34:22 Md. R. 1977); June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended effective October 5, 2009 (36:20 Md. R. 1528); April 19, 2010 (37:8 Md. R. 615); December 27, 2010 (37:26 Md. R. 1787); February 6, 2012 (39:2 Md. R. 141); December 24, 2012 (39:25 Md. R. 1613); December 12, 2013 (40:24 Md. R. 2017); August 29, 2016 (43:17 Md. R. 955); November 7, 2016 (43:22 Md. R. 1221); December 31, 2018 (45:26 Md. R. 1245)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04#B" title="">Regulation .04B</a> amended effective April 10, 2006 (33:7 Md. R. 668); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.04#C" title="">Regulation .04C</a> amended effective June 30, 2008 (35:13 Md. R. 1180); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#I" title="">Regulation .05I</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#G" title="">Regulation .05G</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.05#K" title="">Regulation .05K</a> amended effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.06#C" title="">Regulation .06C</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08" title=".08 Special Needs Populations — Pregnant and Postpartum Women.">Regulation .08</a> amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08#C" title="">Regulation .08C</a>, E amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08#I" title="">Regulation .08I</a> amended effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.08#K" title="">Regulation .08K</a> amended effective April 10, 2006 (33:7 Md. R. 668)</p>
                  <p>Regulation .08M repealed effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#C" title="">Regulation .10C</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#D" title="">Regulation .10D</a> amended effective April 10, 2006 (33:7 Md. R. 668)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#E" title="">Regulation .10E</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.10#F" title="">Regulation .10F</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.11" title=".11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed">Regulation .11</a> repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .11E amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p>Regulation .11F amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p>Regulation .11G amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>Regulation .11-1 repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .11-2 repealed effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.12#B" title="">Regulation .12B</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .12D repealed effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.13#F" title="">Regulation .13F</a> amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.14" title=".14 Referral to Behavioral Health ASO.">Regulation .14</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.14#A" title="">Regulation .14A</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15" title=".15 Data Collection and Reporting.">Regulation .15</a> amended effective February 16, 2015 (42:3 Md. R. 316); February 26, 2018 (45:4 Md. R. 205); December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#B" title="">Regulation .15B</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#C" title="">Regulation .15C</a> amended effective April 9, 2007 (34:7 Md. R. 698)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D" title="">Regulation .15D</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#E" title="">Regulation .15E</a> amended effective December 19, 2005 (32:25 Md. R. 1941); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#F" title="">Regulation .15F</a> amended effective April 10, 2006 (33:7 Md. R. 668)</p>
                  <p>Regulation .15L adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.16" title=".16 Repealed.">Regulation .16</a> repealed effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17" title=".17 Subcontractual Relationships.">Regulation .17</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#A" title="">Regulation .17A</a> amended effective November 6, 2006 (33:22 Md. R. 1732); June 30, 2008 (35:13 Md. R. 1180); February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B" title="">Regulation .17B</a> amended effective April 10, 2006 (33:7 Md. R. 668); June 30, 2008 (35:13 Md. R. 1180); October 5, 2009 (36:20 Md. R. 1528); February 1, 2016 (42:23 Md. R. 1434)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18#H" title="">Regulation .18H</a> amended effective November 5, 2007 (34:22 Md. R. 1977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18#I" title="">Regulation .18I</a>, J adopted effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended as an emergency provision effective April 1, 2005 (32:9 Md. R. 847); amended permanently effective July 18, 2005 (32:14 Md. R. 1276)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#A" title="">Regulation .19A</a>, B amended as an emergency provision effective January 1, 2008 (35:3 Md. R. 286); amended permanently effective June 16, 2008 (35:12 Md. R. 1120)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#A" title="">Regulation .19A</a> amended effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended effective December 20, 2004 (31:25 Md. R.1790); December 19, 2005 (32:25 Md. R. 1941); April 10, 2006 (33:7 Md. R. 669)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective July 1, 2006 (33:20 Md. R. 1610); amended permanently effective October 23, 2006 (33:21 Md. R. 1675)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective January 1, 2007 (34:4 Md. R. 396); amended permanently effective April 9, 2007 (34:7 Md. R. 699)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended as an emergency provision effective September 14, 2007 (34:21 Md. R. 1911); amended permanently effective November 19, 2007 (34:23 Md. R. 2027)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a> amended effective January 12, 2009 (36:1 Md. R. 21); July 27, 2009 (36:15 Md. R. 1166); January 25, 2010 (37:2 Md. R. 67); June 14, 2010 (37:12 Md. R. 800); December 27, 2010 (37:26 Md. R. 1788); April 4, 2011 (37:8 Md. R. 431);  April 30, 2012 (39:8 Md. R. 534); December 10, 2012 (39:24 Md. R. 1577); July 7, 2014 (41:13 Md. R. 752); February 16, 2015 (42:3 Md. R. 316); October 26, 2015 (42:21 Md. R. 1301); May 9, 2016 (43:9 Md. R. 530); February 27, 2017 (44:4 Md. R. 253); March 26, 2018 (45:6 Md. R. 319); August 26, 2019 (46:17 Md. R. 726)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended as an emergency provision effective February 11, 2004 (31:5 Md. R. 446); amended permanently effective May 24, 2004 (31:10 Md. R. 795)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended effective June 14, 2010 (37:12 Md. R. 800); October 26, 2015 (42:21 Md. R. 1301); February 27, 2017 (44:4 Md. R. 253); March 26, 2018 (45:6 Md. R. 319)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-1" title=".19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.">Regulation .19-1</a> adopted as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); adopted permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> amended effective June 19, 2006 (33:12 Md. R. 997); April 9, 2007 (34:7 Md. R. 698); June 14, 2010 (37:12 Md. R. 800); April 30, 2012 (39:8 Md. R. 534)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> repealed effective October 28, 2013 (40:21 Md. R. 1775)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19-3" title=".19-3 MCO-Specific Case Mix Adjustment.">Regulation .19-3</a> adopted effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p>Regulation .19-3A, B amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p>Regulation .19-3A, B amended effective October 5, 2009 (36:20 Md. R. 1528)</p>
                  <p>Regulation .19-3B amended effective December 24, 2012 (39:25 Md. R. 1613); February 3, 2014 (41:2 Md. R. 91)</p>
                  <p>Regulation .19-3C amended effective February 27, 2017 (44:4 Md. R. 253)</p>
                  <p>Regulation .19-3C, D amended effective October 26, 2015 (42:21 Md. R. 1301)</p>
                  <p>Regulation .19-5 adopted effective December 19, 2005 (32:25 Md. R. 1941)</p>
                  <p>Regulation .19-5 repealed and new Regulation .19-5 adopted effective December 31, 2018 (45:26 Md. R. 1244)</p>
                  <p>Regulation .19-5F amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p>Regulation .19-5G amended effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p>Regulation .19-5H amended effective April 19, 2010 (37:8 Md. R. 615); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20</a> amended effective August 8, 2011 (38:16 Md. R. 945); February 26, 2018 (45:4 Md. R. 205)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a> amended effective April 10, 2006 (33:7 Md. R. 668); November 5, 2007 (34:22 Md. R. 1977); December 24, 2012 (39:25 Md. R. 1613); October 28, 2013 (40:21 Md. R. 1775); February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a>, B amended effective November 6, 2006 (33:22 Md. R. 1732); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a>, D amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#B" title="">Regulation .20B</a>, C amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#C" title="">Regulation .20C</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#E" title="">Regulation .20E</a> adopted effective August 29, 2016 (43:17 Md. R. 955)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">Regulation .21</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">Regulation .21</a> amended effective February 16, 2015 (42:3 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21#B" title="">Regulation .21B</a> amended effective June 19, 2006 (33:12 Md. R. 997); April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22</a> amended as an emergency provision effective January 5, 2005 (32:6 Md. R. 634); amended permanently effective April 11, 2005 (32:7 Md. R. 679)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.22#C" title="">Regulation .22C</a>, D amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23" title=".23 Marketing.">Regulation .23</a> amended effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23#C" title="">Regulation .23C</a> amended effective November 7, 2016 (43:22 Md. R. 1221)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23#D" title="">Regulation .23D</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.23#D" title="">Regulation .23D</a> amended effective April 28, 2014 (41:8 Md. R. 471)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> amended as an emergency provision effective November 1, 2008 (35:24 Md. R. 2069); amended permanently effective February 23, 2009 (36:4 Md. R. 353)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.24" title=".24 Repealed.">Regulation .24</a> repealed effective April 19, 2010 (37:8 Md. R. 615)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.25#B" title="">Regulation .25B</a> amended effective November 6, 2006 (33:22 Md. R. 1732)</p>
                  <p>Regulation .28 adopted effective June 30, 2008 (35:13 Md. R. 1180)</p>
                  <p>Regulation .28 amended effective February 6, 2012 (39:2 Md. R. 141)</p>
                  <p>Regulation .28 repealed effective February 26, 2018 (45:4 Md. R. 205)</p>
                  <p>——————</p>
                  <p>Chapter transferred from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.65" title="Chapter 65 Maryland Medicaid Managed Care Program: Managed Care Organizations [Transferred to COMAR 10.67.04]">COMAR 10.09.65</a> effective November 1, 2019 (46:22 Md. R. 977)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03#B" title="">Regulation .03B</a> amended effective April 19, 2021 (48:8 Md. R. 309)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#D" title="">Regulation .15D</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.25#B" title="">Regulation .25B</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.27#C" title="">Regulation .27C</a> amended effective May 18, 2020 (47:10 Md. R. 515)</p>
                  <p>——————</p>
                  <p>Chapter revised effective October 18, 2021 (48:21 Md. R. 889)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.03-1" title=".03-1 HealthChoice Health Equity Incentive Program.">Regulation .03-1</a> repealed and new Regulation .03-1 adopted effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .03-2B amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .03-2L adopted effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .03-2L repealed and new Regulation .03-2 adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p>Regulation .03-2M adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.15#E" title="">Regulation .15E</a> amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.17#B" title="">Regulation .17B</a> amended effective June 13, 2022 (49:12 Md. R. 641)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.18#K" title="">Regulation .18K</a> adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19" title=".19 MCO Reimbursement.">Regulation .19</a> amended effective April 4, 2022 (49:7 Md. R. 468)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B</a>, D amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#D" title="">Regulation .19D</a> amended effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#E" title="">Regulation .19E</a> adopted effective April 28, 2025 (52:8 Md. R. 359)</p>
                  <p>Regulation .19-4A amended effective June 24, 2024 (51:12 Md. R. 620)</p>
                  <p>Regulation .19-4M, N amended effective June 13, 2022 (49:12 Md. R. 641) ​​</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.20#A" title="">Regulation .20A</a>, C amended effective June 24, 2024 (51:12 Md. R. 618)</p>
                  <h2>Authority</h2>
                  <p>Health-General Article, §§2-104, 15-101, 15-102.3, and 15-103; Insurance Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-112" title="">15-112</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-605" title="">15-605</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-1008" title="">15-1008</a>; Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/10.67.04.01" data-order="|10|67|04|.01|" data-ref-path="10|67|04|.01" class="h__section">.01 Incorporation by Reference — Repealed</h2>
                <h2 id="/us/md/exec/comar/10.67.04.02" data-order="|10|67|04|.02|" data-ref-path="10|67|04|.02" class="h__section">.02 Conditions for Participation.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#A">A.</span> An MCO shall have sufficient provider capacity to provide health care services to Program recipients residing in a geographic region no smaller in size than one county or the City of Baltimore.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#B">B.</span> An MCO shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36" title="Chapter 36 General Medical Assistance Provider Participation Criteria">COMAR 10.09.36</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#C">C.</span> An MCO shall enter a memorandum of understanding with each local health department (LHD) in its service area addressing the method by which the MCO and the LHD will collaborate and communicate on matters of mutual interest and concern, including but not limited to the responsibility of the LHD for contact tracing for sexually transmitted diseases and directly observed therapy for tuberculosis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D">D.</span> Assurance Against Insolvency.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(1)">(1)</span> An MCO shall be actuarially sound.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(2)">(2)</span> An applicant shall possess an initial surplus in the amount of $1,500,000 as specified in Health-General Article, §15-102.4(a)(2)(ii), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(3)">(3)</span> If the Commissioner determines and reports to the Secretary that the applicant has an initial surplus that is at least $1,250,000 but less than $1,500,000, before approval the Department shall designate funds in trust sufficient to provide an initial surplus of $1,500,000.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(4)">(4)</span> If the Commissioner determines and reports to the Secretary that the applicant's initial surplus is less than $1,250,000 before approval the Department may, at its discretion, designate funds in trust in an amount equal to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(4)(a)">(a)</span> The sum of the amounts due to the owners of the applicant from the Department for Medicaid services provided on a fee-for-service basis, so long as the owners of the applicant have waived in writing their right to receive Medicaid payments until such time as the Department is permitted to remove its funds from the trust account pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#D(6)" title="">§D(6) of this regulation</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(4)(b)">(b)</span> If a financial guarantor with sufficient net worth and an adequate history of generating net income agrees to pay claims against the MCO in the case of insolvency, the difference between $1,250,000 and the applicant's initial surplus.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(5)">(5)</span> If, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#D(4)" title="">§D(4) of this regulation</a>, the Department designates funds sufficient to increase the applicants initial surplus to $1,250,000, the Department shall designate $250,000 in trust for the applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(6)">(6)</span> Funds designated by the Secretary pursuant to §D(3)(5) of this regulation shall remain in trust until such time as the Commissioner has determined that the MCO meets the minimum statutory surplus requirements based on the MCOs annual report submitted pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=5-605" title="">Insurance Article, §5-605, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(7)">(7)</span> Before approval of an applicant, the Secretary shall notify the Commissioner whether the Secretary has placed any money in trust under this section.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(8)">(8)</span> In the event of insolvency, the MCO shall cover continuation of services to enrollees for the duration of the period for which capitation payment has been made.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)">(9)</span> An MCO shall meet the solvency standards established by the State for private HMOs, or be licensed or certified by the State as a risk-bearing entity except if the MCO:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)(a)">(a)</span> Is a public entity; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)(b)">(b)</span> Is, or is controlled by, one or more federally qualified health centers and meets the solvency standards established by the State for those centers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#D(9)(c)">(c)</span> Has its solvency guaranteed by the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E">E.</span> Health Care Delivery. An MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(1)">(1)</span> Provide the services set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> promptly and continuously, consistent with good medical practice and community professional standards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(2)">(2)</span> Conform with and fulfill the requirements of 42 CFR §422.128, as amended, and provide adult enrollees with written information on advance directives which shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(2)(a)">(a)</span> Include a description of applicable State law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(2)(b)">(b)</span> Reflect a change in State law as soon as possible, but not later than 90 days after the effective date of the change.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)">(3)</span> Provide each enrollee within 10 days of notification to the MCO of the enrollees enrollment with a distinctive, durable identification card, clearly indicating the bearer to be a member of the MCO and containing, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(a)">(a)</span> The enrollee's Medicaid number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(b)">(b)</span> The MCO's consumer services hotline telephone number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(c)">(c)</span> The Department's enrollee hotline telephone number; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(3)(d)">(d)</span> Enrollee's assigned primary care provider's name and telephone number;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(4)">(4)</span> Provide enrollees, within 30 days before the intended effective date, written notice when there is a significant change in the nature or location of services provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)">(5)</span> Provide on the card required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#E(3)" title="">§E(3) of this regulation</a>, on a separate prescription benefit card, or other technology, prescription billing information that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(a)">(a)</span> Complies with the standards set forth in the National Council for Prescription Drug Programs pharmacy ID card prescription benefit card implementation guide at the time of issuance of the card or other technology; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)">(b)</span> Includes, at a minimum, the following data elements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(i)">(i)</span> The name or identifying trademark of the MCO;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(ii)">(ii)</span> The name and identification number of the recipient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(iii)">(iii)</span> The telephone number that providers may call for pharmacy benefit assistance; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#E(5)(b)(iv)">(iv)</span> All electronic transaction routing information and other numbers required by the MCO or its benefit administrator to process a prescription claim electronically.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F">F.</span> An MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(1)">(1)</span> Shall comply with the standards in P.L. 101-336, Americans with Disabilities Act of 1990, 42 U.S.C. §12101 et seq.;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(2)">(2)</span> May not discriminate against an enrollee on any basis, including, but not limited to, age, sex, race, creed, color, marital status, sexual orientation, gender identity, national origin, physical or mental handicap, health status, or need for health care services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)">(3)</span> Shall prepare and make available all publications in a manner consistent with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.01#A" title="">COMAR 10.67.05.01A</a>, including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(a)">(a)</span> Provider directories;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(b)">(b)</span> Enrollee handbooks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(c)">(c)</span> Health education materials; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#F(3)(d)">(d)</span> Informational brochures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#G">G.</span> An MCO shall maintain enrollee medical records in compliance with Health-General Article, §4-301 et seq., Annotated Code of Maryland, and the utilization control requirement of 42 CFR Part 456, as amended.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#H">H.</span> An MCO shall permit the enrollment of a waiver-eligible Program recipient who is enrolled by the Department or who selects the MCO, unless the MCO's enrollment meets or exceeds any enrollment limits mutually agreed to by the Department and the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I">I.</span> MCO Local Access Area Participation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(1)">(1)</span> Effective January 1, 2014, an MCO shall open in all local access areas located within the same county in which the MCO chooses to participate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(2)">(2)</span> The MCO shall provide written notification to the Department of the MCO's intent to participate and accept new enrollees in each of the counties by September 15 for the next calendar year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(3)">(3)</span> The MCO's decision to accept new enrollees is in effect from January 1 to December 31 unless the Department decides there is adequate justification to waive this requirement, which includes, but is not limited to, a rate cut or an MCO exit from the market.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(4)">(4)</span> Unless the Department approves a shorter time frame, an MCO that exits the Program during the calendar year shall submit their exit transition plan to the Department 120 days prior to the effective date of the exit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(5)">(5)</span> If the MCO has not participated in a county for a period of 12 or more consecutive months, the MCO may participate and accept new enrollees in that county by notifying the Department at least 30 days before accepting new enrollees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(6)">(6)</span> An MCO that voluntarily freezes for new enrollments in a county shall remain frozen in that county for the remainder of the calendar year and the following calendar year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(7)">(7)</span> If system modifications require longer than 30 days to implement, the effective date may be extended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#I(8)">(8)</span> The MCO shall follow the access standards specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05.06" title=".06 Geographical Access.">COMAR 10.67.05.06</a> and .05-1.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J">J.</span> In counties where the MCO decides to stop accepting new enrollees, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J(1)">(1)</span> Continue to accept enrollees who regain eligibility within 120 days of becoming ineligible for the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J(2)">(2)</span> Accept newborns if the mother is an MCO member at the time of birth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#J(3)">(3)</span> Accept the family members of enrollees enrolled with the MCO before the effective date that the MCO stopped accepting new enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#K">K.</span> An HMO that is approved as an MCO and that requires its panel providers to participate in an MCO shall submit for review by the Secretary its plan to assure the equitable distribution of enrollees and to ensure that a provider is not assigned a disproportionate number of enrollees, as required by Health-General Article, §15-102.5, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L">L.</span> An MCO shall comply with the provisions of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-112" title="">Insurance Article, §15-112, Annotated Code of Maryland</a> when credentialing providers, and during the credentialing process the MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L(1)">(1)</span> May not discriminate against particular providers that serve high-risk populations or specialize in conditions that require costly treatment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L(2)">(2)</span> May not employ or contract with providers excluded from participation in federal health care programs under either §1128 or 1128A of the Social Security Act; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#L(3)">(3)</span> Shall give the affected providers written notice of the reason for its decision if the MCO declines to include the providers in its network.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M">M.</span> The requirements of <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#A(2)" title="">Regulation .17A(2) of this chapter</a>, or <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#L(1)" title="">§L(1) of this regulation</a>, may not be construed to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(1)">(1)</span> Require an MCO to contract with providers beyond the number necessary to meet the needs of its enrollees;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(2)">(2)</span> Preclude an MCO from using different reimbursement amounts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(2)(a)">(a)</span> For different specialties; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(2)(b)">(b)</span> For different practitioners in the same specialty; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#M(3)">(3)</span> Preclude an MCO from establishing measures that are designed to maintain quality of services and control costs, consistent with its responsibilities to enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N">N.</span> Disclosure of Provider Incentive Plans.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(1)">(1)</span> An MCO shall disclose to the Department the information on its provider incentive plans listed in 42 CFR §417.479(h)(1):</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(1)(a)">(a)</span> Prior to approval of its contract or agreement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(1)(b)">(b)</span> Upon the contract's or agreement's anniversary or renewal effective date.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#N(2)">(2)</span> An MCO shall include in the disclosures required by <a class="internal-link " href="/us/md/exec/comar/10.67.04.02#N(1)" title="">§N(1) of this regulation</a> information sufficient for the Department to determine whether the incentive plans meet the requirements of 42 CFR §417.479(d)(g) and, as applicable (i), when there exist compensation arrangements under which payment for designated health services furnished to an individual on the basis of a physician referral would otherwise be denied under §1903(a) of the Social Security Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#O">O.</span> When making a referral, an MCO shall use the uniform consultation referral form adopted by the Maryland Insurance Administration at <a class="internal-link no-wrap" href="/us/md/exec/comar/31.10.12.06" title=".06 General Provisions.">COMAR 31.10.12.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P">P.</span> An MCO shall meet all other requirements of applicable State and federal law including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(1)">(1)</span> Title VI of the Civil Rights Act of 1964;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(2)">(2)</span> Title IX of the Education Amendments of 1972 regarding education programs and activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(3)">(3)</span> The Age Discrimination Act of 1975;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(4)">(4)</span> The Rehabilitation Act of 1973;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(5)">(5)</span> Any laws regarding privacy and confidentiality;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(6)">(6)</span> Any laws that pertain to enrollee rights;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(7)">(7)</span> 45 CFR Part 74, as amended, including particular attention to requirements at 45 CFR §§74.42, 74.43, 74.44, 74.48, and 74. 53(a) and (b), and Appendix A; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#P(8)">(8)</span> Section 1557 of the Affordable Care Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#Q">Q.</span> An MCO shall meet all program integrity requirements as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07" title="Chapter 07 Maryland Medicaid Managed Care Program: Program Integrity">COMAR 10.67.07</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R">R.</span> The following applies to the Department's Health Home Program as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.33" title="Chapter 33 Health Homes">COMAR 10.09.33</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(1)">(1)</span> The MCO may not provide services that duplicate the CMS reimbursed health home services for members participating in the State's Health Home Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(2)">(2)</span> The State shall inform the MCO of members assigned to the State's Health Home Program so that the MCO can prepare to coordinate care with the health homes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(3)">(3)</span> The MCO shall provide a point of contact for the health homes to the State who shall share with all the enrolled health homes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(4)">(4)</span> The MCO shall make referrals to the health homes of members who meet the criteria for enrollment in the program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(5)">(5)</span> To facilitate this process, the State shall provide information to the MCO on all the enrolled health homes in the MCO's service areas; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.02#R(6)">(6)</span> The MCO shall assist the health homes as necessary in accessing somatic care services for health home recipients.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.03" data-order="|10|67|04|.03|" data-ref-path="10|67|04|.03" class="h__section">.03 Quality Assessment and Improvement.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A">A.</span> An MCO shall have a continuous, systematic program designed to monitor, measure, evaluate, and improve the quality of health care services delivered to enrollees including individuals with special health care needs. At a minimum, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(1)">(1)</span> Comply with all applicable federal and State laws and regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(2)">(2)</span> Comply with all access and quality standards and levels of performance established by the Department including all standards for individuals with special health care needs in Regulations.04—.10 of this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)">(3)</span> Be able to provide the Department with timely accurate information in areas including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(a)">(a)</span> Provider networks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(b)">(b)</span> Utilization of services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)">(c)</span> Identification and management of individuals with special health care needs, including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(i)">(i)</span> Enrollees with HIV;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(ii)">(ii)</span> Pregnant women;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(iii)">(iii)</span> Enrollees with disabilities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(iv)">(iv)</span> Adult enrollees with diabetes;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(v)">(v)</span> Pediatric enrollees with asthma; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#A(3)(c)(vi)">(vi)</span> Children with special health care needs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B">B.</span> An MCO shall participate in all quality assessment activities required by the Department to determine if the MCO is providing medically necessary enrollee health care. These activities include, but are not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)">(1)</span> A Systems Performance Review (SPR) performed by an external quality review organization hired by the Department to assess an MCO’s structure and operations in order to determine its ability to provide health care to its enrollees as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)">(a)</span> The SPR shall include, but not be limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(i)">(i)</span> MCO's Quality Assessment and Improvement program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(ii)">(ii)</span> Enrollee rights;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(iii)">(iii)</span> Access and availability of services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(iv)">(iv)</span> Care management;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(v)">(v)</span> Enrollee outreach;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(vi)">(vi)</span> Utilization management and review; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(a)(vii)">(vii)</span> MCO organization, operations, and financial management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(b)">(b)</span> The results of the SPR shall be reported in draft to the MCOs for comment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(c)">(c)</span> MCO shall submit all comments and any required corrective action within 45 days of receipt of draft report; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(1)(d)">(d)</span> The Department shall issue a final report of the SPR results;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(2)">(2)</span> The annual collection, validation, and evaluation of the latest approved version of the Healthcare Effectiveness Data and Information Set (HEDIS) in order to assess the access to and quality of services provided, in addition to any additional performance measures specified by the Department or CMS;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)">(3)</span> The annual collection and evaluation of a set of performance measures with targets as determined by the Department as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(a)">(a)</span> The composition of the core performance measures is listed in §B(3)(d)—(f) of this regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(b)">(b)</span> Each year before the audit period begins, the Department shall identify and obtain public input on all measures to be collected as well as the target for each;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(c)">(c)</span> In accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.67.10</a>, MCOs may receive financial or other types of incentives or disincentives based on performance measure results;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)">(d)</span> Effective January 1, 2017, the core performance measures are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(i)">(i)</span> Adolescent well care visits;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(ii)">(ii)</span> Adult Body Mass Index (BMI) assessment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(iii)">(iii)</span> Ambulatory care for Supplemental Security Income (SSI) adults;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(iv)">(iv)</span> Ambulatory care for Supplemental Security Income (SSI) children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(v)">(v)</span> Breast cancer screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(vi)">(vi)</span> Childhood immunizations — Combo 3;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(vii)">(vii)</span> Comprehensive diabetes care — HbA1c testing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(viii)">(viii)</span> Controlling high blood pressure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(ix)">(ix)</span> Immunization for adolescents;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(x)">(x)</span> Lead screening for children 12—23 months old;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(xi)">(xi)</span> Asthma medication ratio;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(xii)">(xii)</span> Postpartum care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(d)(xiii)">(xiii)</span> Well child visits, 3—6 years old;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)">(e)</span> Effective January 1, 2019, the core performance measures are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(i)">(i)</span> Adolescent well care visits;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(ii)">(ii)</span> Ambulatory care for SSI adults;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(iii)">(iii)</span> Ambulatory care for SSI children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(iv)">(iv)</span> Asthma medication ratio;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(v)">(v)</span> Breast cancer screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(vi)">(vi)</span> Comprehensive diabetes care — HbA1c control (&lt;8.0%);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(vii)">(vii)</span> Controlling high blood pressure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(viii)">(viii)</span> Lead screening for children 12 through 23 months old; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(e)(ix)">(ix)</span> Well child visits in the first 15 months of life;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)">(f)</span> Effective January 1, 2021, the core performance measures are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(i)">(i)</span> Adolescent well care visits;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(ii)">(ii)</span> Ambulatory care for SSI adults;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(iii)">(iii)</span> Ambulatory care for SSI children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(iv)">(iv)</span> Asthma medication ratio;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(v)">(v)</span> Breast cancer screening;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(vi)">(vi)</span> Comprehensive diabetes care — HbA1c control (&lt;8.0%);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(vii)">(vii)</span> Controlling high blood pressure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(viii)">(viii)</span> Lead screening for children 12 through 23 months old;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(ix)">(ix)</span> Postpartum care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(f)(x)">(x)</span> Well child visits in the first 15 months of life;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)">(g)</span> Starting with the 2019 performance measures, the Department shall implement the following methodology for imposing penalties and incentives:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(i)">(i)</span> There shall be three levels of performance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(ii)">(ii)</span> Performance shall be evaluated separately for each measure, and each measure shall have equal weight;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(iii)">(iii)</span> On any of the measures in §B(3)(f)(i)—(ix) of this regulation for which the MCO does not meet the minimum target, as determined by the Department, a penalty of 1/9 of 1 percent of the total capitation amount paid to the MCO during the measurement year shall be collected;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(iv)">(iv)</span> The total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a> may not exceed 1 percent of the total capitation amount paid to the MCO during the same measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(v)">(v)</span> On any of the measures in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(f)" title="">§B(3)(f) of this regulation</a> for which the MCO meets or exceeds the incentive target, as determined by the Department, the MCO shall be paid an incentive payment of up to 1/9 of 1 percent of the total capitation paid to the MCO during that measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(vi)">(vi)</span> The total amount of the incentive payments as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(v)" title="">§B(3)(h)(v) of this regulation</a> paid to the MCOs each year may not exceed the total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(g)(iii)" title="">§B(3)(g)(iii) of this regulation</a> collected from the MCOs in that same year, plus any additional funds allocated to the Department for a quality initiative; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(g)(vii)">(vii)</span> Any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(v)" title="">§B(3)(h)(v) of this regulation</a> shall be distributed to the MCOs receiving the four highest normalized scores for Value Based Purchasing for all ten performance measures at a rate calculated by multiplying each MCO’s adjusted enrollment as of December 31 of the measurement year by a per enrollee amount;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)">(h)</span> Starting with the 2021 performance measures, the Department shall implement the following methodology for imposing penalties and incentives:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(i)">(i)</span> There shall be three levels of performance;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(ii)">(ii)</span> Performance shall be evaluated separately for each measure, and each measure shall have equal weight;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)">(iii)</span> On any of the measures in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(f)" title="">§B(3)(f) of this regulation</a> for which the MCO does not meet the minimum target, as determined by the Department, a penalty of 1/10 of 1 percent of the total capitation amount paid to the MCO during the measurement year shall be collected if the conditions in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iv)" title="">§B(3)(h)(iv) of this regulation</a> do not apply;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(iv)">(iv)</span> If the Department’s actuary determines that the MCO’s total capitation amount for the measurement year does not meet the actuarial soundness definition described in 42 CFR §438.4 after collection of the total penalty amount described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a>, the Department’s actuary shall calculate the maximum penalty the Department shall apply that results in the MCO’s total capitation for the measurement year remaining actuarially sound;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(v)">(v)</span> If the MCO’s penalty amount is reduced as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iv)" title="">§B(3)(h)(iv) of this regulation</a>, the Department may impose any of the additional sanctions described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.67.10</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(vi)">(vi)</span> The total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a> may not exceed 1 percent of the total capitation amount paid to the MCO during the same measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)">(vii)</span> On any of the measures in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(f)" title="">§B(3)(f) of this regulation</a> for which the MCO meets or exceeds the incentive target, as determined by the Department, the MCO shall be paid an incentive payment of up to 1/10 of 1 percent of the total capitation paid to the MCO during that measurement year;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(viii)">(viii)</span> The total amount of the incentive payments as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be paid to the MCOs with total amount of the penalties as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(iii)" title="">§B(3)(h)(iii) of this regulation</a> collected from the MCOs in that same year, plus additional reserves in the HealthChoice Performance Incentive Fund if the total amount of the penalties collected is insufficient to pay the total amount of the incentive payments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(ix)">(ix)</span> 40 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be distributed to the MCOs earning net incentives with the four highest normalized scores, at a rate calculated by multiplying each MCO’s adjusted enrollment as of December 31 of the measurement year by a per-enrollee amount;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(x)">(x)</span> MCOs earning net disincentives are ineligible to receive the funds described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(ix)" title="">§B(3)(h)(ix) of this regulation</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xi)">(xi)</span> 25 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be distributed to the MCOs that the Department determines have demonstrated performance improvement in the measurement year, provided that the MCOs use the funding to target performance improvement in areas defined by the Department;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xii)">(xii)</span> 25 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be retained for health improvement programs under the Maryland Medicaid Managed Care Program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xiii)">(xiii)</span> 10 percent of any funds remaining after the payment of the incentives due under <a class="internal-link " href="/us/md/exec/comar/10.67.04.03#B(3)(h)(vii)" title="">§B(3)(h)(vii) of this regulation</a> shall be used to establish a reserve in the HealthChoice Performance Incentive Fund, to be used in any calendar year when the amount of penalties collected is insufficient to pay incentives earned by MCOs; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(h)(xiv)">(xiv)</span> If the amount in the HealthChoice Performance Incentive Fund exceeds $5,000,000, the Department shall equally allocate the remaining 10 percent of funds for use in §B(3)(h)(ix)—(xii);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)">(i)</span> The adjusted enrollment amount in §§B(3)(g)(vii) and B(3)(h)(ix) of this regulation shall be calculated by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(i)">(i)</span> Multiplying four times the enrollment of the MCO with the highest normalized score;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(ii)">(ii)</span> Multiplying three times the enrollment of the MCO with the second highest normalized score;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(iii)">(iii)</span> Multiplying two times the enrollment of the MCO with the third highest normalized score; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(i)(iv)">(iv)</span> Using the actual enrollment of the MCO with the fourth highest normalized score;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(j)">(j)</span> The per enrollee amount in §§B(3)(g)(vii) and B(3)(h)(ix) of this regulation shall be calculated by dividing the sum of the calculations in §B(3)(i)(i)—(iv) of this regulation into the funds remaining as described in §§B(3)(g)(vii) and B(3)(h)(ix) of this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(3)(k)">(k)</span> The methodology described in §B(3)(a)—(j) of this regulation shall remain in effect through December 31, 2021;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(4)">(4)</span> An annual enrollee satisfaction survey using the latest version of the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey tool, conducted by an NCQA-certified CAHPS vendor;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)">(5)</span> An annual Maryland Healthy Kids audit in order to determine the quality of the clinical care provided to all children younger than 21 years old enrolled in the HealthChoice Program as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)(a)">(a)</span> The audit shall include a review of a sample of medical records from each provider reviewed during the calendar year to assess clinical care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)(b)">(b)</span> The results of the audit that are below minimum EPSDT standards may result in corrective action required by both the provider and the MCO; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(5)(c)">(c)</span> The Department shall issue a final report of the audit results;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)">(6)</span> Performance improvement projects to be conducted by the MCOs that focus on clinical or nonclinical areas as determined by the Department or CMS and include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(a)">(a)</span> Measurement of performance using objective quality indicators;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(b)">(b)</span> Implementation of system interventions to achieve improvement in quality;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(c)">(c)</span> Evaluation of effectiveness of interventions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(d)">(d)</span> Planning and initiation of activities to sustain improvement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(6)(e)">(e)</span> Reporting of results to the Department or CMS; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#B(7)">(7)</span> Validation and evaluation of MCO provider networks to ensure compliance with the network adequacy and access standards set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.05" title="Chapter 05 Maryland Medicaid Managed Care Program: Access">COMAR 10.67.05</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#C">C.</span> If an MCO is assessed as deficient in accordance with federal and State standards, the MCO shall submit a plan of corrective action to the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D">D.</span> An MCO shall provide the Department a copy of its most recent NCQA accreditation, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(1)">(1)</span> Accreditation status, survey type, and level;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)">(2)</span> Accreditation results, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)(a)">(a)</span> Recommended actions or improvements;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)(b)">(b)</span> Corrective action plans; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(2)(c)">(c)</span> Summaries of findings; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03#D(3)">(3)</span> Expiration date of the accreditation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.03-1" data-order="|10|67|04|.03-1|" data-ref-path="10|67|04|.03-1" class="h__section">.03-1 HealthChoice Health Equity Incentive Program.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#A">A.</span> The Department shall award a defined amount of funding annually to MCOs based on the county of residence of their members and the socioeconomic disadvantage index described in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B">B.</span> Socioeconomic Disadvantage Index.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)">(1)</span> The Department shall calculate a ranking for each service area in Maryland in accordance with the following domains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(a)">(a)</span> Community safety;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(b)">(b)</span> Food security;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(c)">(c)</span> Housing security; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(1)(d)">(d)</span> Transportation access.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(2)">(2)</span> The Department shall select component measures and calculate rankings that aggregate to the domains defined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03-1#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(3)">(3)</span> Rankings shall range from first to twenty-fourth, with first being the lowest ranking for socioeconomic disadvantage and twenty-fourth being the highest ranking for socioeconomic disadvantage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#B(4)">(4)</span> Each service area shall be assigned a single summary score by calculating the equal-weighted average across each service area’s domain rankings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C">C.</span> The Department shall award available equity funding to MCOs serving members in Maryland service areas based on the following criteria:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C(1)">(1)</span> Allocation of equity funding shall be made proportionally to the MCO’s membership in the service areas at the top quartile of the socioeconomic disadvantage index.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C(2)">(2)</span> Funding for each calendar year shall be determined based on available funding in the Department’s budget and specified in the annual HealthChoice Managed Care Organization Agreement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#C(3)">(3)</span> The annual allocation for HealthChoice Health Equity Incentive Program shall be funded outside of managed care capitation rates.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-1#D">D.</span> Incentive funds awarded under the HealthChoice Health Equity Incentive Program are not appealable under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">10.67.10</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.03-2" data-order="|10|67|04|.03-2|" data-ref-path="10|67|04|.03-2" class="h__section">.03-2 HealthChoice Population Health Incentive Program (PHIP).</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#A">A.</span> Effective January 1, 2022, the Department shall establish the HealthChoice Population Health Incentive Program (PHIP).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B">B.</span> An MCO may be eligible for an incentive payment for the following performance measures:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(1)">(1)</span> Ambulatory care visits for Supplemental Security Income (SSI) adults;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(2)">(2)</span> Ambulatory care visits for Supplemental Security Income (SSI) children;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(3)">(3)</span> HEDIS asthma medication ratio;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(4)">(4)</span> Hemoglobin A1c control for patients with diabetes — poor control (&gt;9.0%);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(5)">(5)</span> Lead screening measures:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(5)(a)">(a)</span> Lead screening measure for children 1223 months old; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(5)(b)">(b)</span> HEDIS lead screening in children;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(6)">(6)</span> HEDIS postpartum care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(7)">(7)</span> HEDIS risk of continued opioid use  &gt;=31 days covered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#B(8)">(8)</span> HEDIS timeliness of prenatal care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#C">C.</span> Each measure identified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03-2#B" title="">§B of this regulation</a> shall be valued equally at a proportional share of available incentive funds, except for measures §B(5)(a) and (b), which are each valued at half of the available incentive funds relative to one of the other measures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#D">D.</span> There shall be two rounds of potential incentive payments an MCO may earn.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#E">E.</span> Subject to budget approval, total PHIP funding shall be determined prior to the measurement year and included in the MCO contract.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#F">F.</span> All PHIP payments shall be funded independently from and outside of MCO capitation payments during a given calendar year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#G">G.</span> Each MCO shall be eligible for no more than 1 percent of the plan's measurement year capitation payments, excluding supplemental payments outside of capitation, as total payment from round one and round two.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#H">H.</span> If the Department determines that the score for any measure identified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.03-2#B" title="">§B of this regulation</a> may not be comparable to the previous year's score due to alterations in measure specifications or other factors, the Department may exclude the measure from the PHIP and adjust the incentive valuation in accordance with the remaining performance measures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I">I.</span> Round One Incentives.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(1)">(1)</span> An MCO may earn two types of incentives in round one:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(1)(a)">(a)</span> A performance incentive payment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(1)(b)">(b)</span> An improvement incentive payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(2)">(2)</span> If an MCO does not report a performance measure or an MCO has a performance score of 0 percent, then the MCO is awarded no performance or improvement incentive payments for this measure.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)">(3)</span> Performance Incentive Payments for Round One.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)">(a)</span> Performance incentive payments shall be based on the following categories for each performance measure:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)(i)">(i)</span> Superlative performance, meaning the performance measure's score is at or above the 90th percentile of HEDIS Medicaid performance nationwide during the measurement year, or estimated 90th percentile among Maryland HealthChoice MCO performance for non-HEDIS performance measures;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)(ii)">(ii)</span> Very strong performance, meaning the performance measure's score is between the 75th and 89th percentiles, inclusive, of HEDIS Medicaid performance nationwide during the measurement year, or between the estimated 75th and 89th percentiles, inclusive, among Maryland HealthChoice MCO performance for non-HEDIS performance measures; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(a)(iii)">(iii)</span> Strong performance, meaning the performance measure's score is between the 50th and 74th percentiles, inclusive, of HEDIS Medicaid performance nationwide during the measurement year, or between the estimated 50th and 74th percentiles, inclusive, among Maryland HealthChoice MCO performance for non-HEDIS performance measures.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)">(b)</span> Payments for round one performance incentives shall be allocated as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(i)">(i)</span> For superlative performance, an MCO may earn 100 percent of the incentive allocation for the performance measure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(ii)">(ii)</span> For very strong performance, an MCO may earn 66.6 percent of the incentive allocation for the performance measure;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(iii)">(iii)</span> For strong performance, an MCO may earn 33.3 percent of the incentive allocation for the performance measure; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(3)(b)(iv)">(iv)</span> Any MCO earning a performance measure score below the 50th percentile of HEDIS Medicaid performance nationwide during the measurement year on a HEDIS-based measure, or below the calculated 50th percentile among Maryland HealthChoice MCO performance for a non-HEDIS measure, shall be ineligible for a round one performance incentive payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)">(4)</span> Round One Improvement Incentive Payments.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(a)">(a)</span> An MCO may earn an improvement incentive payment of 33.3 percent of the incentive allocation for any performance measure if the following conditions are met:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(a)(i)">(i)</span> The MCO demonstrates improvement of at least 0.5 percentage points in the measure compared to the previous measurement year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(a)(ii)">(ii)</span> The performance measure score is at or above the 50th percentile of HEDIS Medicaid performance nationwide on a HEDIS-based measure, or the 50th percentile of Maryland HealthChoice MCO performance for a non-HEDIS measure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(b)">(b)</span> An MCO earning a superlative performance incentive payment for a performance measure is ineligible for an improvement incentive payment for the same measure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(c)">(c)</span> For any performance measures in which a lower score indicates stronger performance, year-over-year improvement is demonstrated by a reduction in the score for that measure.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#I(4)(d)">(d)</span> If an MCO is missing or zero-valued for a performance measure in the previous year, then no improvement incentive will be awarded in the measurement year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J">J.</span> Round Two Incentive Payments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(1)">(1)</span> An MCO may qualify for payments under round two if the following conditions are met:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(1)(a)">(a)</span> The MCO earned above 80 percent of possible round one incentives; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(1)(b)">(b)</span> The MCO did not have penalties applied during the measurement year for failure to meet the HEDIS MCO Performance Monitoring Policy included in the MCO contract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(2)">(2)</span> Any remaining funds that were unallocated during round one may be awarded to eligible MCOs in round two for a maximum incentive award of up to 1 percent of its total capitation payment during the PHIP measurement year, excluding supplemental payments outside of capitation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#J(3)">(3)</span> If any remaining funds that were unallocated during round one are not sufficient to settle all qualifying MCOs up to 1 percent of capitation in round two, then the leftover funds will be awarded proportionally among qualifying MCOs based on enrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#K">K.</span> If additional funds remain after both round one and round two, the Department may, within its discretion, allocate the funding as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#K(1)">(1)</span> Make additional payments to MCOs that are below 1 percent of capitation based on improvement or performance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#K(2)">(2)</span> Place remaining funds into a nonlapsing pool.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#L">L.</span> Effective measurement year 2025, an MCO with penalties under the HEDIS MCO Performance Monitoring Policy included in the HealthChoice MCO Agreement shall be excluded from all rounds of PHIP for that measurement year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.03-2#M">M.</span> Incentives awarded under this regulation and exclusion from PHIP participation are not appealable under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10" title="Chapter 10 Maryland Medicaid Managed Care Program: Sanctions">COMAR 10.67.10</a>..</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.04" data-order="|10|67|04|.04|" data-ref-path="10|67|04|.04" class="h__section">.04 Special Needs Populations.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#A">A.</span> An MCO shall provide health care services to enrollees who are members of special needs populations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B">B.</span> Special needs populations consist of the following non-mutually exclusive populations:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(1)">(1)</span> Children with special health care needs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(2)">(2)</span> Individuals with a physical disability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(3)">(3)</span> Individuals with a developmental disability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(4)">(4)</span> Pregnant and postpartum women;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(5)">(5)</span> Individuals who are homeless;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(6)">(6)</span> Individuals with HIV/AIDS; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#B(7)">(7)</span> Children in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C">C.</span> General Requirements for Special Needs Populations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(1)">(1)</span> An MCO shall demonstrate that its pediatric and adult primary care providers (PCPs) and specialists are clinically qualified based upon generally accepted community standards to provide or arrange for the provision of appropriate health care services to individuals who are members of a special needs population. The MCO shall submit to the Department referral protocols that demonstrate the conditions under which PCPs will make the arrangements for referrals to specialty care networks.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(2)">(2)</span> Clinical qualifications are to be determined through the MCO's credentialing and recredentialing processes, including a review of the provider's medical education, special training, and work history and experience.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)">(3)</span> Specialty and subspecialty providers shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)(a)">(a)</span> Have experience in treating individuals within a special needs population;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)(b)">(b)</span> Have experience in interdisciplinary medical management; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(3)(c)">(c)</span> Understand the relationship between somatic and behavioral health care issues and interventions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(4)">(4)</span> The MCO shall demonstrate the use of a primary care system of care delivery which includes a comprehensive plan of care for an enrollee who is a member of a special needs population and which uses a coordinated and continuous case management approach, involving the enrollee and, as appropriate, the enrollee's family, guardian, or caregiver, in all aspects of care, including primary, acute, tertiary, and home care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)">(5)</span> To meet the commitment outlined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.04#C(4)" title="">§C(4) of this regulation</a>, an MCO shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(a)">(a)</span> Provide case management services to adult and pediatric enrollees as appropriate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(b)">(b)</span> Have the capacity to perform home visits as part of the ongoing case management program and have the ability to respond to urgent care needs while in the enrollee's home;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(c)">(c)</span> Ensure that, if warranted, a case manager is assigned to an enrollee at the time of the initial health screen by the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(d)">(d)</span> Ensure that the PCP, who may also be the specialist, shall be the admitting or referring provider for all hospital admissions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(e)">(e)</span> Ensure that it will:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(e)(i)">(i)</span> Collaborate with inpatient facilities in facilitating preadmission and discharge planning, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(e)(ii)">(ii)</span> Communicate all post-discharge home and community arrangements to the enrollee, the PCP, and, as appropriate, the enrollee's family, guardian, and caregiver;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(f)">(f)</span> Document the plan of care and treatment modalities provided to enrollees in special populations, assuring that the plan of care:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(f)(i)">(i)</span> Is updated at least annually, when the enrollee’s circumstances or needs change significantly, or at the enrollee’s request; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(f)(ii)">(ii)</span> Involves the enrollee and, as appropriate, the enrollee's family, guardian, and caregiver in care decisions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(5)(g)">(g)</span> Be familiar with community and social support providers for the special populations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)">(6)</span> An MCO shall make documented outreach efforts to contact and educate enrollees who fail to appear for appointments or who have been noncompliant with a regimen of care. These efforts may include, but may not be limited to, notification:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(a)">(a)</span> By mail;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(b)">(b)</span> By telephone;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(c)">(c)</span> By email;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(d)">(d)</span> By text messaging; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(6)(e)">(e)</span> Through face-to-face contact.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)">(7)</span> Referral to Local Health Department.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(a)">(a)</span> An MCO shall make a written referral, or ensure that the enrollee's provider makes a written referral, to the local health department (LHD) for the county in which an enrollee resides, for assistance in bringing into care an enrollee for whom the MCO has been unsuccessful in its documented out-reach efforts pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.04#C(6)" title="">§C(6) of this regulation</a>, within 10 business days of whichever first occurs:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(a)(i)">(i)</span> The third consecutive missed appointment; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(a)(ii)">(ii)</span> The MCO or the enrollee's provider identifies the enrollee's repeated noncompliance with a regimen of care.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(7)(b)">(b)</span> The MCO may not include information about an enrollee's HIV status on the form used to refer an enrollee to the local health department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(8)">(8)</span> An MCO shall subject its decision to deny a service authorization request or to authorize a service in an amount, duration, or scope that is less than requested, for an enrollee who is a member of special needs population to utilization review that includes review by a health care professional who has appropriate clinical expertise in treating the enrollee's condition or disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)">(9)</span> An MCO shall identify a special needs coordinator, who shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(a)">(a)</span> Serve as a point of contact for health care services information and referral for members of special needs populations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(b)">(b)</span> Be skilled in communications with, and sensitive to the unique needs of, members of special needs populations, their families, guardians, and caregivers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(c)">(c)</span> Participate on the MCO's consumer advisory board, pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.12" title=".12 Consumer Advisory Board.">Regulation .12 of this chapter</a>, as a representative of special needs populations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(d)">(d)</span> Serve as a resource to MCO providers and enrollees on the requirements of P.L. 101-330, Americans with Disabilities Act of 1990, 42 U.S.C. §12101 et seq.; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(9)(e)">(e)</span> Maintain a log of each denial of treatment and the outcome of the utilization review conducted pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.04#C(8)" title="">§C(8) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.04#C(10)">(10)</span> An MCO shall have mechanisms in place to allow enrollees with special health care needs to access a specialist directly as appropriate for the enrollee’s condition and identified needs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.05" data-order="|10|67|04|.05|" data-ref-path="10|67|04|.05" class="h__section">.05 Special Needs Populations — Children with Special Health Care Needs.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating children with special health care needs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#B">B.</span> The Department shall maintain a record of the complaints received through the Department's enrollee and provider hotlines which involve the denial of care for children and review these complaint logs as part of its quality assurance system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C">C.</span> An MCO shall demonstrate that its therapies provider network is adequate by demonstrating its:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C(1)">(1)</span> Providers' pediatric specialties;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C(2)">(2)</span> Collaboration with schools that provide IEP or IFSP services to its enrollees, where available; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#C(3)">(3)</span> Provision of family-focused services and development of family-focused plans of care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#D">D.</span> An MCO shall provide case management services to children with special health care needs as appropriate. For complex cases involving multiple medical interventions or social services, or both, a multidisciplinary team shall be used to review and develop the plan of care for special health care needs children.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#E">E.</span> An MCO shall provide coordinated care for special health care needs children in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F">F.</span> An MCO shall refer child victims of alleged abuse, neglect, or sexual offense to an appropriate provider capable of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F(1)">(1)</span> Determining if the alleged abuse, neglect, or sexual offense occurred;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F(2)">(2)</span> Determining if medical intervention is needed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#F(3)">(3)</span> Ensuring the preservation of evidence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#G">G.</span> An MCO shall ensure coordination with the Department’s Early and Periodic Screening, Diagnosis and Treatment (EPSDT) program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#H">H.</span> An MCO shall establish protocols for effecting medically necessary service referrals to specialty care providers for children with special health care needs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I">I.</span> The service referrals referenced in <a class="internal-link " href="/us/md/exec/comar/10.67.04.05#H" title="">§H of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(1)">(1)</span> Include services intended to improve or preserve the continuing health and quality of life for children with special health care needs, regardless of the ability of the services to effect permanent cure; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)">(2)</span> Be made when the child is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(a)">(a)</span> Identified as being at risk of a developmental delay by the developmental screen required by EPSDT;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(b)">(b)</span> Experiencing a delay of 25 percent or more in any developmental area as measured by appropriate diagnostic instruments and procedures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(c)">(c)</span> Manifesting atypical development or behavior; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#I(2)(d)">(d)</span> Diagnosed with a physical or mental condition that has a high probability of resulting in developmental delay.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#J">J.</span> An MCO shall provide durable medical equipment to a special needs child in a timely manner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K">K.</span> When a child, who is an MCO enrollee, is diagnosed with a special health care need requiring a plan of care which includes specialty services, and that health care need was undiagnosed at the time of enrollment, the parent or guardian of that child may request approval from the MCO for a specific out-of-network specialty provider to provide those services when the MCO does not have a local in-network specialty provider with the same professional training and expertise who is reasonably available and provides the same service and modality, subject to the following provisions:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K(1)">(1)</span> If the MCO denies the request for an out-of-network provider referral, the child's parent or guardian may initiate the complaint and appeal process set forth at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">COMAR 10.67.09.05</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K(2)">(2)</span> If at any time the MCO decides to terminate or reduce services provided by the approved out-of-network provider, the child's parent or guardian may initiate the complaint and appeal process set forth at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09.05" title=".05 MCO Appeal Process for Enrollees.">COMAR 10.67.09.05</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.05#K(3)">(3)</span> The MCO shall continue to cover the services of the out-of-network provider during the course of the appeal until such time as the Office of Administrative Hearings issues its decision.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.06" data-order="|10|67|04|.06|" data-ref-path="10|67|04|.06" class="h__section">.06 Special Needs Populations — Individuals with a Physical Disability.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating an individual with a physical disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#B">B.</span> An MCO shall demonstrate that its providers for durable medical equipment and assistive technology provide the appropriate services and are clinically qualified to provide these services to the individual with a physical disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C">C.</span> Before placement of an individual with a physical disability into an intermediate or long-term care facility, an MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C(1)">(1)</span> Recommend that an individual with a physical disability be transferred to an intermediate or long-term care facility only after assessing the needs of the individual and the ability of the MCO to meet these needs in the community as supplemented by other Medicaid services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C(2)">(2)</span> Conduct a second opinion review of the case, performed by the MCO's medical director, before a transfer to an intermediate care facility or a long-term care facility is implemented; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#C(3)">(3)</span> If the MCO's medical director determines that the transfer to an intermediate or long- term care facility is medically necessary and that the expected stay will be greater than 30 days, obtain approval from the Department before making the transfer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#D">D.</span> An MCO shall utilize individuals with expertise in disabilities to review its marketing and informational forms and publications, which shall be provided in alternative formats with reasonable accommodation to people with a physical disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.06#E">E.</span> An MCO shall provide education for the MCO's member services staff, triage staff, and case managers on special communications requirements for individuals with physical disabilities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.07" data-order="|10|67|04|.07|" data-ref-path="10|67|04|.07" class="h__section">.07 Special Needs Populations — Individuals with a Developmental Disability.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating an individual with a developmental disability.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#B">B.</span> An MCO shall ensure that its case managers have experience or training related to developmental disabilities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#C">C.</span> An MCO shall utilize individuals with expertise in disabilities to review its marketing and informational forms and publications, which shall be provided in alternative formats with reasonable accommodation to people with developmental disabilities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.07#D">D.</span> An MCO shall provide education for the MCO's member services staff, triage staff, and case managers on special communications requirements for individuals with developmental disabilities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.08" data-order="|10|67|04|.08|" data-ref-path="10|67|04|.08" class="h__section">.08 Special Needs Populations — Pregnant and Postpartum Women.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating pregnant and postpartum women.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B">B.</span> An MCO shall ensure access to prenatal care for pregnant women and postpartum care for postpartum women by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(1)">(1)</span> Scheduling an appointment for the first prenatal visit and seeing the woman within 10 days of request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(2)">(2)</span> Scheduling an appointment for a postpartum woman and seeing the woman within 10 days of request:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(3)">(3)</span> Arranging for an adequate network of providers including obstetricians, gynecologists, perinatologists, neonatologists, anesthesiologists, and advanced practice nurses who are capable of addressing complex maternal and infant health issues; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#B(4)">(4)</span> Linking a pregnant woman with a pediatric provider before delivery.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#C">C.</span> An MCO shall ensure that prenatal providers:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#C(1)">(1)</span> Complete a prenatal risk assessment, using an instrument approved by the Department, at the first prenatal visit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#C(2)">(2)</span> Within 10 days of completing the prenatal risk assessment, forward this instrument to the local health department in the jurisdiction in which the pregnant enrollee lives.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#D">D.</span> The Department may not include questions about a woman's HIV infection status on the prenatal risk assessment instrument.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#E">E.</span> An MCO shall refer pregnant and postpartum women with a substance use disorder to the behavioral health ASO for substance use treatment within 24 hours of request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#F">F.</span> An MCO shall refer pregnant and postpartum women, infants, and children younger than 5 years old to the WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) Program, and shall provide to WIC necessary medical information to determine WIC nutritional eligibility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#G">G.</span> An MCO shall follow, at a minimum, the American College of Obstetricians and Gynecologists (ACOG) guidelines for pregnant and postpartum women.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#H">H.</span> An MCO shall provide risk-related medical and nonmedical preventive treatment services, including nutrition counseling by licensed nutritionists or dietitians and smoking cessation education and treatment for pregnant and postpartum women.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#I">I.</span> An MCO shall provide HIV counseling, including a risk assessment and information about possible transmission of HIV to the fetus.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#J">J.</span> An MCO shall offer its pregnant and postpartum enrollees voluntary HIV counseling and testing following the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.08#K">K.</span> An MCO shall arrange for the appropriate emergency transfer of pregnant women, newborns, and infants to tertiary care centers.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.09" data-order="|10|67|04|.09|" data-ref-path="10|67|04|.09" class="h__section">.09 Special Needs Populations — Homeless Individuals.</h2>
                <p>An MCO's initial health screen shall attempt to identify homeless individuals and link them to the appropriate provider of services.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.10" data-order="|10|67|04|.10|" data-ref-path="10|67|04|.10" class="h__section">.10 Special Needs Populations — Individuals with HIV/AIDS.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#A">A.</span> An MCO shall meet the standards set forth in this regulation for treating individuals with HIV/AIDS.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B">B.</span> HIV/AIDS Specialist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(1)">(1)</span> An MCO shall allow an enrollee with HIV/AIDS to choose an HIV/AIDS specialist for treatment and coordination of primary and specialty care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)">(2)</span> To qualify as an HIV/AIDS specialist, a health care provider shall be board certified in the field of infectious diseases by a member board of the American Board of Medical Specialties or:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)">(a)</span> Hold a current, valid, unrevoked, and unsuspended Maryland license or certification as a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(i)">(i)</span> Doctor of medicine;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(ii)">(ii)</span> Doctor of osteopathy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(iii)">(iii)</span> Nurse practitioner; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(a)(iv)">(iv)</span> Physician's assistant being supervised by a medical doctor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(b)">(b)</span> Have provided direct, continuous, ongoing care for at least 20 patients with HIV over the past 2 years; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)">(c)</span> Have completed one of the following requirements:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(i)">(i)</span> If a medical doctor, certified physician's assistant being supervised by a medical doctor, or doctor of osteopathy, at least 30 hours of HIV-related continuing medical education category I credits over the past 2 years;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(ii)">(ii)</span> If a nurse practitioner, at least 30 hours of HIV-related continuing education units over the past 2 years;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(iii)">(iii)</span> If a medical doctor, certified physician's assistant being supervised by a medical doctor, doctor of osteopathy, or a nurse practitioner, an accredited training program over the past year; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#B(2)(c)(iv)">(iv)</span> If a medical doctor, certified physician's assistant being supervised by a medical doctor, doctor of osteopathy, or a nurse practitioner, has completed the American Academy of HIV Medicine (AAHIVM) credentialing examination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C">C.</span> AIDS Case Management Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)">(1)</span> An MCO shall ensure that an enrollee with HIV/AIDS receives case management services that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(a)">(a)</span> Link the enrollee with the full range of available benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)">(b)</span> Link the enrollee with any additional needed services including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(i)">(i)</span> Mental health services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(ii)">(ii)</span> Substance abuse services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(iii)">(iii)</span> Medical services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(iv)">(iv)</span> Social services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(v)">(v)</span> Financial services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(vi)">(vi)</span> Counseling services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(vii)">(vii)</span> Educational services;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(viii)">(viii)</span> Housing services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(b)(ix)">(ix)</span> Other required support services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(c)">(c)</span> Ensure timely and coordinated access to medically necessary levels of care that support continuity of care across the continuum of service providers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(d)">(d)</span> Are performed by licensed physicians, physician assistants, advanced practice nurses, registered nurses, social workers, or other individuals who are appropriately trained, experienced, and supervised by a licensed practitioner; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)">(e)</span> Include, but are not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(i)">(i)</span> Initial and ongoing assessment of the enrollee's needs and personal support systems, including the MCO offering an enrollee one face-to-face meeting during the initial assessment and documenting the enrollee's acceptance or declination of the face to face meeting;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(ii)">(ii)</span> Development of a comprehensive, individualized service plan, using a multidisciplinary approach;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(iii)">(iii)</span> Coordination of the services required to implement the plan;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(iv)">(iv)</span> Periodic reevaluation and adaptation of the plan as necessary over the life of the enrollee;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(v)">(v)</span> Development of an outreach system for the enrollee and family by which the case manager and primary care provider track services received, clinical outcomes, and the need for additional follow-up; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(1)(e)(vi)">(vi)</span> Serving as an effective enrollee advocate to resolve differences between the enrollee and providers of care pertaining to the course or content of therapeutic interventions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#C(2)">(2)</span> An enrollee diagnosed with HIV/AIDS shall be offered case management services by the MCO at any time after diagnosis. An enrollee who has previously refused these services may request case management from the MCO at any time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D">D.</span> Diagnostic Evaluation Service (DES) Assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(1)">(1)</span> An MCO shall offer a diagnostic evaluation service (DES) assessment annually and document the enrollee's acceptance or declination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(2)">(2)</span> The DES shall consist of a comprehensive medical and psychosocial assessment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(3)">(3)</span> A DES provider shall use assessment and care plan forms used by the Department for adult and pediatric assessments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(4)">(4)</span> An individual shall select a DES provider from an approved list of sites, and may select a DES provider which is not part of the individual's MCO if so desired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#D(5)">(5)</span> An MCO and other qualified institutions may become DES providers as provided in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.32.03#C" title="">COMAR 10.09.32.03C</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#E">E.</span> An individual with HIV/AIDS who has a substance use disorder shall be referred to the behavioral health ASO for substance abuse treatment within 24 hours of request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#F">F.</span> Clinical Trials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#F(1)">(1)</span> An MCO may refer enrollees who are individuals with HIV/AIDS to facilities or organizations that can provide the enrollees' access to clinical trials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.10#F(2)">(2)</span> An MCO shall provide enrollees with HIV/AIDS access to clinical trials in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.26" title=".26 Benefits — Primary Mental Health Services.">COMAR 10.67.06.26</a>-1.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.11" data-order="|10|67|04|.11|" data-ref-path="10|67|04|.11" class="h__section">.11 Special Needs Populations — Individuals in Need of Substance Abuse Treatment — Repealed</h2>
                <h2 id="/us/md/exec/comar/10.67.04.12" data-order="|10|67|04|.12|" data-ref-path="10|67|04|.12" class="h__section">.12 Consumer Advisory Board.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#A">A.</span> An MCO shall establish a consumer advisory board to facilitate the receipt of input from enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#B">B.</span> The consumer advisory board membership shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#B(1)">(1)</span> Consist of enrollees and enrollees' family members, guardians, or caregivers; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#B(2)">(2)</span> Be comprised of no less than one third representation from the MCO’s special needs populations, or their representatives and the MCO’s special needs coordinator.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.12#C">C.</span> The consumer advisory board shall meet at least 6 times a year.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.13" data-order="|10|67|04|.13|" data-ref-path="10|67|04|.13" class="h__section">.13 Children in State-Supervised Care.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#A">A.</span> An MCO shall provide or arrange to provide all Medicaid-covered services required to comply with State statutes and regulations mandating health and mental health services for children in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#B">B.</span> An MCO shall ensure the continuity and coordination of care, provided locally to the extent the services are available, to an enrollee who is a child in State-supervised care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#C">C.</span> An enrollee who is a child in State-supervised care who moves shall be disenrolled from the recipient's MCO and enrolled in an alternative MCO if the recipient's current MCO does not serve the geographic region to which the child has been relocated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#D">D.</span> An MCO shall expedite a change of providers within its provider panel upon the move of an enrollee who is a child in State-supervised care to a new geographic area served by the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#E">E.</span> On request of the responsible State or local agency, a child in State-supervised care may be disenrolled from the current MCO and enrolled in an MCO serving the group facility in which the child resides, members of the foster care family, or other children in foster care placement with the child.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#F">F.</span> Enrollee Self-Referral. An MCO shall permit the self-referral of a child in State-supervised care to an EPSDT certified provider for an initial examination, including a mental health screen, and shall pay for all portions of the examination except for the mental health screen, which shall be paid for by the Specialty Mental Health System.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.13#G">G.</span> Coordination with Responsible Agency. An MCO shall appoint a liaison to coordinate services to a child in State-supervised care with the responsible State or local agencies.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.14" data-order="|10|67|04|.14|" data-ref-path="10|67|04|.14" class="h__section">.14 Referral to Behavioral Health ASO.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#A">A.</span> An MCO is responsible for providing medically necessary primary behavioral health services to their enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#B">B.</span> An enrollee may self-refer to the behavioral health ASO for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#C">C.</span> If an enrollee’s primary care physician determines that primary behavioral health services are not sufficient to meet the enrollee’s needs, the primary care physician shall refer the enrollee to the behavioral health ASO for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#D">D.</span> If an MCO determines that primary behavioral health services are not sufficient to meet the enrollee’s needs, the MCO shall refer the enrollee to the behavioral health ASO for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59" title="Chapter 59 Specialty Mental Health Services">COMAR 10.09.59</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80" title="Chapter 80 Community-Based Substance Use Disorder Services">10.09.80</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.14#E">E.</span> An MCO shall cooperate with the behavioral health ASO in developing referral procedures and protocols.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.15" data-order="|10|67|04|.15|" data-ref-path="10|67|04|.15" class="h__section">.15 Data Collection and Reporting.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#A">A.</span> An MCO shall notify the Department immediately when it has knowledge of an enrollee's death.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B">B.</span> Encounter Data.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(1)">(1)</span> An MCO shall submit encounter data reflecting 100 percent of provider-enrollee encounters, in CMS1500 and UB04 format or an alternative format previously approved by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(2)">(2)</span> An MCO may use alternative formats including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(2)(a)">(a)</span> ASC X12N 837 and NCPDP formats; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(2)(b)">(b)</span> ASC X12N 835 format, as appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)">(3)</span> An MCO shall submit encounter data that identifies the provider who delivers any items or services to enrollees at a frequency and level of detail to be specified by CMS and the Department, including, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(a)">(a)</span> Enrollee and provider identifying information;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(b)">(b)</span> Service, procedure, and diagnoses codes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(c)">(c)</span> Allowed, paid, enrollee responsibility, and third-party liability amounts; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(3)(d)">(d)</span> Service, claims submission, adjudication, and payment dates.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(4)">(4)</span> An MCO shall report encounter data within 60 calendar days after receipt of the claim from the provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#B(5)">(5)</span> An MCO shall submit encounter data utilizing a secure on-line data transfer system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#C">C.</span> Monthly Reports.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#C(1)">(1)</span> An MCO shall provide an updated list of the PCP's assigned enrollees to each PCP at least on a monthly basis.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#C(2)">(2)</span> An MCO shall participate in the electronic enrollment reconciliation process to identify discrepancies in enrollment data between the Department and the MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D">D.</span> Quarterly Reports. An MCO shall submit to the Department:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(1)">(1)</span> Within 30 calendar days of the close of each calendar quarter, quality assurance reports including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(1)(a)">(a)</span> Quality assurance committee meeting minutes reflecting major quality assurance corrective action plans, initiatives, and activities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(1)(b)">(b)</span> An analysis of recipient appeal and grievance logs including significant trends or anomalies, what caused the trend or anomaly, and any actions taken to address the trend or anomaly;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(2)">(2)</span> Within 30 calendar days after the close of each calendar quarter, in the format specified by the Department, a list of all pre-service denials or reduction of services or benefits issued by the MCO or MCO subcontractors during the preceding quarter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(3)">(3)</span> Within 30 calendar days of the close of each calendar quarter, third-party liability collection activities as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18#D" title="">Regulation .18D of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(4)">(4)</span> In a format specified by the Department, amounts the MCO has cost-avoided and recovered and the number of cases the MCO has handled in each case area during the quarter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)">(5)</span> Not later than 45 days after the end of each quarterly rebate period, drug utilization data necessary for the Department to bill manufacturers for rebates in accordance with §1927(b)(1)(A) of the Social Security Act, that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)">(a)</span> Include, at a minimum, the following information by National Drug Code of each covered outpatient drug dispensed or covered by the MCO:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)(i)">(i)</span> Total number of units of each dosage form;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)(ii)">(ii)</span> Total number of units of each dosage strength; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(a)(iii)">(iii)</span> Total number of units of each dosage package size; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(5)(b)">(b)</span> Distinguish utilization data for covered outpatient drugs that are subject to discounts under the 340B drug pricing program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#D(6)">(6)</span> Within 10 calendar days after the close of each calendar quarter, in the format specified by the Department, a list of all State fair hearing outcomes during the preceding quarter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E">E.</span> Annual Reports. Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.15#E(5)" title="">§E(5) of this regulation</a>, an MCO shall submit to the Department annually, within 90 days after the end of the calendar year:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(1)">(1)</span> A summary of the information contained in <a class="internal-link " href="/us/md/exec/comar/10.67.04.15#D(1)(b)" title="">§D(1)(b) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(2)">(2)</span> A report of the MCO's consumer advisory board outlining the board's activities and recommendations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(3)">(3)</span> A copy of the MCO's drug formulary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(4)">(4)</span> Any revisions to the MCOs quality assurance, utilization management, and case management plans;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)">(5)</span> HealthChoice Financial Monitoring Reports (HFMRs), including any supplemental schedules required by the Department:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(a)">(a)</span> In the format required by the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(b)">(b)</span> Prepared according to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(b)(i)">(i)</span> The criteria, set forth in Regulation .19-5 of this chapter, for allocating MCO costs to HFMR expense categories; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(b)(ii)">(ii)</span> Reporting instructions provided by the Department for the HFMR form and any required supplemental schedules; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(c)">(c)</span> Submitted according to the following schedule:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(c)(i)">(i)</span> Services incurred from January 1 through December 31 of the prior year, reported through March 31 of the current year — due on May 15 of the current year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(5)(c)(ii)">(ii)</span> Services incurred January 1 through December 31 of the prior year, reported through June 30 of the current year — due on September 1 of the current year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#E(6)">(6)</span> A detailed description of its drug utilization program activities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F">F.</span> Unless the MCO is exempt for good cause, an MCO shall submit to the Department when requested the following reports for its enrollee/member services and provider/authorization/preauthorization lines:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F(1)">(1)</span> Caller abandonment rates;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F(2)">(2)</span> Caller service level rates; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#F(3)">(3)</span> Caller average hold time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G">G.</span> If the MCO exits the HealthChoice Program for any reason, including those listed in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.06#A(1)(e)" title="">COMAR 10.67.02.06A(1)(e)</a> and (f):</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(1)">(1)</span> The MCO shall provide the Department with a list of enrollees and the name of each enrollee's PCP, at least 30 days before exiting the program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(2)">(2)</span> On receiving the list provided by the MCO, the Department shall provide the list to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(2)(a)">(a)</span> The health benefits exchange to assist and provide outreach to participants in selecting an MCO; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#G(2)(b)">(b)</span> If permitted by State and federal law, the remaining MCOs for linking participants with a PCP.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#H">H.</span> Jurisdictional Reporting to Local Health Departments. The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#H(1)">(1)</span> Aggregate by jurisdiction the encounter data it receives from MCOs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#H(2)">(2)</span> Provide to local health departments jurisdiction-specific information based on aggregated encounter data for public health monitoring and assessment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#I">I.</span> For the purposes of Maryland Medicaid Managed Care Program administration or monitoring MCO performance pursuant to this chapter, the MCO shall supply other information as the Department may from time to time request, given a reasonable period of notice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#J">J.</span> Nonfederally qualified MCOs shall report a description of certain transactions with parties of interest, as described in §1903(m)(4)(A) of the Social Security Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.15#K">K.</span> Upon request, an MCO whose member has disenrolled shall transfer historical utilization data to the member's new MCO in the time frame and format specified by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.16" data-order="|10|67|04|.16|" data-ref-path="10|67|04|.16" class="h__section">.16 Repealed.</h2>
                <h2 id="/us/md/exec/comar/10.67.04.17" data-order="|10|67|04|.17|" data-ref-path="10|67|04|.17" class="h__section">.17 Subcontractual Relationships.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A">A.</span> Subcontracting Permitted.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(1)">(1)</span> Consistent with this regulation, an MCO may subcontract services that it is required to provide to its enrollees under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> to a health care provider that is licensed, certified, or otherwise legally authorized to provide those services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(2)">(2)</span> An MCO may not discriminate for the participation, reimbursement, or indemnification of any provider who is acting within the scope of the provider's license or certification under applicable State law, solely on the basis of that license or certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)">(3)</span> An MCO shall have written agreements with subcontractors that comply with 42 CFR §§438.214 and 455.105, as amended, and include at least the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(a)">(a)</span> A provision that the subcontractor be subject to all of the requirements to which the MCO is subject under its contract with the Department and pursuant to the Department's regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(b)">(b)</span> A clear description of the services to be performed under the subcontract sufficient to definitively inform the Department which of the MCO's obligations have been subcontracted;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(c)">(c)</span> A provision for the subcontractor's release to the MCO and to the Department, upon request, of any information necessary for the MCO to perform any of its contractual and regulatory obligations under its contract with the Department, including, but not limited to, its records, reporting, and quality assurance duties;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(d)">(d)</span> A provision requiring that the subcontractor complies with all State and federal requirements regarding audit, inspection, and evaluation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(e)">(e)</span> A provision that copies of the subcontractor's medical records pertaining to the MCO's enrollees shall be furnished to the MCO upon request for transfer to a subsequent provider in the event of a termination of the subcontract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(f)">(f)</span> A provision to the effect that no termination of the subcontract shall be effective without prior written notice to the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(g)">(g)</span> An agreement that the subcontractor will look solely to the MCO for compensation for covered services provided to the MCO's enrollees under the subcontract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(h)">(h)</span> An assurance that evidence of the subcontractor's professional liability coverage will be submitted annually to the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(i)">(i)</span> A provision that no assignment of the subcontract by the subcontractor is effective without prior written notice to the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(j)">(j)</span> If the subcontractor is authorized by the MCO to make referrals, a provision requiring the subcontractor to use the uniform consultation referral form adopted by the Maryland Insurance Administration at <a class="internal-link no-wrap" href="/us/md/exec/comar/31.10.12.06" title=".06 General Provisions.">COMAR 31.10.12.06</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(k)">(k)</span> A provision to the effect that each provision of the subcontract that is required under this section supersede and be controlling over any conflicting terms that appear in the subcontract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(l)">(l)</span> A provision for revocation of the delegation of activities or obligations, or specifying other remedies in instances where the Department or the MCO determines that the subcontractor has not performed satisfactorily;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(m)">(m)</span> A provision stating that the MCO has the right to audit the subcontractor pursuant to 42 CFR §438.230(c)(3)(i) for 10 years from the final date of the contract period or from the date of completion of any audit, whichever is later; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(3)(n)">(n)</span> A provision to the effect that all providers and subcontractors are subject to a grievance and appeal system consistent with the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.09" title="Chapter 09 Maryland Medicaid Managed Care Program: MCO Dispute Resolution Procedures">COMAR 10.67.09</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(4)">(4)</span> An MCO may not subcontract for hospital services with a hospital or an entity related to a hospital unless that hospital is in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.37.12" title="Chapter 12 Cross-Subsidization">COMAR 10.37.12</a> (fixed price contracting regulations).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)">(5)</span> An MCO may not prohibit or otherwise restrict a health care professional, acting within the lawful scope of practice, from advising or advocating on behalf of an enrollee who is the provider's patient for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(a)">(a)</span> The enrollee's health status, medical care, or treatment options, including any alternative treatment that may be self-administered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(b)">(b)</span> Any information the enrollee needs in order to decide among all relevant treatment options;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(c)">(c)</span> The risks, benefits, and consequences of treatment or nontreatment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#A(5)(d)">(d)</span> The enrollee's right to participate in decisions regarding the enrollee's own health care, including the right to refuse treatment, and to express preferences about future treatment decisions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B">B.</span> Subcontractual Relations Reporting Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(1)">(1)</span> An MCO shall submit its standard subcontract to the Department for its approval at least 30 days in advance of the MCO entering into any subcontracts covered by this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(2)">(2)</span> An MCO shall submit to the Department for its prior approval material modifications to, or deviations from, its approved standard subcontract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(3)">(3)</span> An MCO shall submit to the Department a specification of procedures to be followed when reallocating responsibility in the event of a change in obligations in its approved standard subcontract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)">(4)</span> Network Provider Termination.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(a)">(a)</span> When an MCO and provider terminate their contract the MCO shall provide the Department with a written notice regarding the termination.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(b)">(b)</span> If the MCO is terminating the contract, the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#B(4)(a)" title="">§B(4)(a) of this regulation</a> shall be provided at the later of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(b)(i)">(i)</span> 30 calendar days before the effective date of the termination; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(b)(ii)">(ii)</span> 15 calendar days after receipt or issuance of the termination notice.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(c)">(c)</span> If the provider is terminating the contract, the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#B(4)(a)" title="">§B(4)(a) of this regulation</a> shall be provided within 15 days after the MCO receives the notice from the terminating provider.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)">(d)</span> If 50 to 99 enrollees are affected, the notice shall contain the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(i)">(i)</span> Date of termination;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(ii)">(ii)</span> Name or names of providers or subcontractors terminating;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(iii)">(iii)</span> Number of enrollees affected; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(d)(iv)">(iv)</span> MCO's plan for transitioning enrollees to other providers.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(e)">(e)</span> If more than 99 enrollees are affected, the MCO shall provide the Department with a Department-approved termination survey.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(f)">(f)</span> In determining the number of enrollees affected under §B(4)(d) and (e) of this regulation, the MCO shall consider:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(f)(i)">(i)</span> For PCPs, the number of enrollees assigned to the PCP; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(4)(f)(ii)">(ii)</span> For all other providers, the number of enrollees who are in active treatment or who have had an encounter with the provider in the previous 12 months.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)">(5)</span> Subcontractor Termination.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)">(a)</span> When an MCO terminates a subcontract impacting its operations, covered services, or enrollees, the MCO shall provide the Department with written notice regarding the termination that describes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(i)">(i)</span> The dollar amount of the subcontract;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(ii)">(ii)</span> The effect of the termination on MCO operations;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(iii)">(iii)</span> The effect of the termination on MCO covered services or enrollees; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(a)(iv)">(iv)</span> The MCO’s plan to replace the subcontractor, if applicable.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#B(5)(b)">(b)</span> If the termination of the subcontract impacts MCO operations, the notice required in <a class="internal-link " href="/us/md/exec/comar/10.67.04.17#B(5)(a)" title="">§B(5)(a) of this regulation</a> shall be provided at least 90 days before the effective date of the termination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#C">C.</span> By entering into a subcontract to provide health care services on behalf of an MCO, the subcontractor becomes subject to all the requirements concerning audits and inspections by the Department and other government agencies that are imposed upon the MCO by statute or regulation, or by its contract with the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#D">D.</span> An MCO shall monitor the performance of its subcontractors, including, but not limited to, the areas of enrollee and provider complaints, access issues, quality assurance activities, record keeping, and reporting requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.17#E">E.</span> An MCO shall report to the Department any material deviations from required procedures by its subcontractor which, in the MCO's judgment, can be expected to have a significant effect on quality of care, or on enrollees' ability to access care.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.18" data-order="|10|67|04|.18|" data-ref-path="10|67|04|.18" class="h__section">.18 Third-Party Liability.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#A">A.</span> An MCO is responsible for the identification of, and collection of, moneys owing from responsible third parties liable for the cost of medical care furnished by the MCO to enrollees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#B">B.</span> Upon request from the Department or the U.S. Department of Health and Human Services, an MCO shall convey any information regarding third-party liability to the Department, to the U.S. Department of Health and Human Services, or to another MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#C">C.</span> The Department shall notify an MCO of any third-party liability identified during the course of eligibility determination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#D">D.</span> The MCO shall submit to the Department any new or changed third-party information in an automated format on a monthly basis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#E">E.</span> The Department shall provide the MCOs with any new or changed information on a monthly basis in an automated format.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F">F.</span> In order to facilitate the Department's and the U.S. Department of Health and Human Services' monitoring of its third-party liability collection activities, an MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(1)">(1)</span> Submit to the Department, on a monthly basis, reports on third-party collections and activities during the month, including but not limited to amounts the MCO has cost-avoided and recovered and current accounts receivable for all third-party liability cases;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(2)">(2)</span> Submit to the Department, on a quarterly basis and in a format specified by the Department, amounts the MCO has cost-avoided and recovered and the number of cases the MCO has handled in each case area during the quarter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(3)">(3)</span> Cooperate in site inspections by either the Department or the U.S. Department of Health and Human Services for monitoring purposes; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#F(4)">(4)</span> Submit a detailed report of third-party liability collection activities including, but not limited to, cost avoidance, recovered amounts, and current amounts receivable for cases selected by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#G">G.</span> When both the Department and an MCO have a right of subrogation, they shall coordinate settlement negotiation, ensuring that the funds available are prorated to allow sufficient compensation to settle each party's claim amount.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#H">H.</span> For insurance coverage identified by an MCO with a retroactive effective date, an MCO shall comply with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gin&amp;section=15-1008" title="">Insurance Article, §15-1008, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#I">I.</span> An MCO may not deny a provider’s request for a preauthorization solely because a recipient has, or is thought to have, third-party insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#J">J.</span> The requirement in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18#I" title="">§I of this regulation</a> may not apply if an MCO has a process in place to ensure that a claim will not be denied for lack of preauthorization if the claim ultimately becomes the MCOs responsibility for one of the following reasons:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#J(1)">(1)</span> The recipient does not have third-party insurance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#J(2)">(2)</span> The service received is a noncovered service under the third-party insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K">K.</span> If an MCO identifies another party as being responsible for retroactive denial of reimbursement, the MCO shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(1)">(1)</span> Obtain a written statement from the third-party that includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(1)(a)">(a)</span> The name and address of the third party; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(1)(b)">(b)</span> Acknowledgment of responsibility for payment of the denied claim by the third party;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(2)">(2)</span> Send this written statement to the provider seeking reimbursement; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18#K(3)">(3)</span> Provide this written statement or a summary report to the Department upon request.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.18-1" data-order="|10|67|04|.18-1|" data-ref-path="10|67|04|.18-1" class="h__section">.18-1 MCO Reimbursement — GME Exclusion.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A">A.</span> Capitation Rate Setting Methodology — Extraction of Graduate Medical Education Costs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)">(1)</span> Percentage of Teaching Hospitals' Rates Representing GME Costs. The Department, in consultation with the HSCRC, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)">(a)</span> Determine the amount, expressed as a percentage, of payments by the Program that are attributable to GME, based on historic cost and discharge abstract data that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(i)">(i)</span> Are specific to each individual teaching hospital;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(ii)">(ii)</span> Are specific to Program recipients who would have been MCO-eligible if <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01" title="Chapter 01 Maryland Medicaid Managed Care Program: Definitions">COMAR 10.67.01</a>—.12 had been in effect at the time the activity reflected in the data occurred;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(iii)">(iii)</span> Reflect services that would be, if performed during the contract year to which calculations utilizing a teaching hospital's GME percentage amount relate, included in the mandatory MCO benefits package described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(a)(iv)">(iv)</span> Represent activity in FY 1995; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(1)(b)">(b)</span> For any teaching hospital that is not in compliance with the primary care and innovation requirements of COMAR 10.10.67.11, reduce the Program's payments to the hospital deemed to be attributable to GME pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(1)(a)" title="">§A(1)(a) of this regulation</a> by the hospital's noncompliance penalty percentage derived in accordance with COMAR 10.67.11.03C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)">(2)</span> GME Percentage Start-Up Adjustment. To ameliorate the impact on MCOs that historically have experienced low utilization of teaching hospitals, the Department shall, during the first 3 years of separate GME funding, reduce the GME percentage determined in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(1)" title="">§A(1) of this regulation</a> in the following amounts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(a)">(a)</span> FY 1999 ... 10 percent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(b)">(b)</span> FY 2000 ... 6.7 percent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(c)">(c)</span> FY 2001 ... 3.3 percent; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(2)(d)">(d)</span> FY 2002 and thereafter ... 0 percent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)">(3)</span> Modifying GME Percentage to Maintain Budget Neutrality.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(a)">(a)</span> To maintain budget neutrality in the GME funding procedure established pursuant to this regulation and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11" title="Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.67.11</a>, the Department may modify the GME percentages established pursuant to §A(1) and (2) of this regulation.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(b)">(b)</span> The Department may use the modified GME percentage authorized by <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(3)(a)" title="">§A(3)(a) of this regulation</a> to calculate non-GME teaching hospital costs pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)" title="">§A(4) of this regulation</a>, for the purpose of equalizing:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(b)(i)">(i)</span> The amount of GME costs to be excluded from capitation rates for the contract year pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)" title="">§A(4) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(b)(ii)">(ii)</span> The amount of GME allocation payments, determined pursuant to COMAR 10.67.11.03C.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(3)(c)">(c)</span> Application of the GME percentage modification authorized in §A(3)(a) and (b) of this regulation does not affect the amount of the GME allocation payments made pursuant to COMAR 10.67.11.03C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)">(4)</span> GME Adjustment in Capitation Rate-Setting Methodology.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(a)">(a)</span> Before determining the average historic costs assigned to the rate cells set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>, the Department shall, consistent with §A(1)—(3) of this regulation, deduct, for each rate cell, the dollar amount allocatable to GME contained in the Department's base year payments to teaching hospitals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(b)">(b)</span> The deduction referenced in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)(a)" title="">§A(4)(a) of this regulation</a> is calculated as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(b)(i)">(i)</span> For each payment included in the base year data made by the Program to a teaching hospital in the contract year, the amount of the payment is multiplied by the hospital-specific GME percentage, established pursuant to §A(1)—(3) of this regulation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(4)(b)(ii)">(ii)</span> The dollar amount attributable to GME that is included in the base year payments, as identified by the procedure described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)(b)(i)" title="">§A(4)(b)(i) of this regulation</a>, is subtracted from the total amount of the payment to yield the non-GME portion of the payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)">(5)</span> Consistent with <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(4)" title="">§A(4) of this regulation</a>, the Department shall use the GME percentage rates calculated pursuant to §A(1)—(3) of this regulation for purposes of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(a)">(a)</span> Calculating each teaching hospital's GME allocation payment amounts pursuant to COMAR 10.67.11.03C;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(b)">(b)</span> Determining the amount of each ACG's average non-GME historic costs for grouping ACGs to make risk adjustment category assignments of the ACGs pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(c)">(c)</span> Determining the amount of each demographic grouping's average non-GME historic costs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#A(5)(d)">(d)</span> Determining, for each risk adjustment category and demographic grouping, the capitation rates set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B">B.</span> The Department shall use, in calculating the capitation rates set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B" title="">Regulation .19B of this chapter</a>, a capitation rate-setting methodology that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)">(1)</span> Excludes the dollar amount allocatable to GME, consistent with the percentage of GME included in historic payments made by the Program to teaching hospitals that receive GME allocation payments in the contract year, based on calculations that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)(a)">(a)</span> Are consistent with <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A" title="">§A of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)(b)">(b)</span> Reflect any modifications made pursuant to §A(2) and (3) of this regulation to the percentage of the Program's historic payments made to teaching hospitals allocable to GME; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(1)(c)">(c)</span> Reflect the reduction of hospital-specific GME percentages, by operation of COMAR 10.67.11.03C and <a class="internal-link " href="/us/md/exec/comar/10.67.04.18-1#A(1)(b)" title="">§A(1)(b) of this regulation</a>, to decrease the amount of GME allocation payments made, pursuant to COMAR 10.67.11.03B, to teaching hospitals that are not in compliance with the primary care and innovation requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.11" title="Chapter 11 Maryland Medicaid Managed Care Program: Contribution to Graduate Medical Education Costs">COMAR 10.67.11</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(2)">(2)</span> Reduces historic costs to reflect savings expected to result from a managed care delivery system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(3)">(3)</span> Includes a trend factor to account for cost differences between the base year and the contract year;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(4)">(4)</span> Excludes the dollar amount of historic payments determined, based on an aggregation of individual inpatients' payment data for the base year, to be avoidable by an MCO pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22 of this chapter</a>, had the services been furnished during the contract year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.18-1#B(5)">(5)</span> Beginning in FY 2000, takes into account Maryland Medicaid Managed Care Program enrollment of the newly eligible population entering the Program pursuant to the Maryland Children's Health Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.19" data-order="|10|67|04|.19|" data-ref-path="10|67|04|.19" class="h__section">.19 MCO Reimbursement.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A">A.</span> Generally.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(1)">(1)</span> Payment to an MCO for each enrollee shall be at a fixed capitation rate, as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">§B(4) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(2)">(2)</span> An MCO shall be reimbursed at rates set forth in this regulation only for individuals enrolled under the Maryland Medicaid Managed Care Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(3)">(3)</span> The capitation rate paid to an MCO by the Department shall be accepted as payment in full for all benefits provided by the MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(4)">(4)</span> An MCO shall conform to the Department's computer coding requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(5)">(5)</span> A capitation payment may not be made to an MCO on behalf of an enrollee for whom capitation payment for the same period has been made to any other MCO having an agreement with the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(6)">(6)</span> The Department may consider a retroactive capitation payment to an MCO, if the MCO notifies the Department within 9 months of the first missed capitation payment for an enrollee for whom the MCO has not received all appropriate capitation payments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#A(7)">(7)</span> Monies collected by an MCO for third party liability, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.18" title=".18 Third-Party Liability.">Regulation .18 of this chapter</a>, are considered when calculating the capitation payments in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">§B(4) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B">B.</span> Capitation Rate-Setting Methodology.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)">(1)</span> Families and Children. Capitation rates for enrollees who are waiver-eligible based upon receipt of benefits through TCA or programs for medically needy families and children, including SOBRA children and Maryland Children's Health Program (MCHP), shall be established as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)">(a)</span> For enrollees eligible under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A(1)" title="">COMAR 10.67.02.01A(1)</a> or (3), and for children eligible under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A(2)" title="">COMAR 10.67.02.01A(2)</a> for whom the Department has sufficient clinical data, the Department shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)(i)">(i)</span> Determine an adjusted clinical group (ACG) assignment utilizing an enrollee's past diagnostic record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)(ii)">(ii)</span> Utilizing aggregated enrollee ACG data, on an annual basis define a limited number of risk adjustment categories that reflect levels of relatively homogenous resource utilization by ACG assignment; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(a)(iii)">(iii)</span> Assign an enrollee to a risk adjustment category based upon the enrollee's ACG assignment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(b)">(b)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(1)(c)" title="">§B(1)(c) of this regulation</a>, for enrollees for whom the Department has insufficient data to generate an ACG assignment, the Department shall assign the enrollee to a risk adjustment category that reflects the enrollee's:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(b)(i)">(i)</span> Age, residence, and gender; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(b)(ii)">(ii)</span> Birth weight with respect to an enrollee born after December 31, 2004; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(c)">(c)</span> On the basis of the enrollee's residence, the Department shall assign:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(c)(i)">(i)</span> All SOBRA mothers enrolled pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.02.01#A(2)" title="">COMAR 10.67.02.01A(2)</a> to one of the two "SOBRA mother" payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">§B(4)(a) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(1)(c)(ii)">(ii)</span> Enrollees with HIV to one of the two HIV payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">§B(4)(a) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)">(2)</span> Disabled. Capitation rates for enrollees who are waiver-eligible based upon receipt of benefits through SSI or as medically needy, aged, blind, or disabled shall be established as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)">(a)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(2)(c)" title="">§B(2)(c) of this regulation</a>, for enrollees for whom the Department has sufficient clinical data, the Department shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)(i)">(i)</span> Determine an adjusted clinical group (ACG) assignment utilizing an enrollee's diagnostic record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)(ii)">(ii)</span> Utilizing aggregated enrollee ACG data, on an annual basis define a limited number of risk adjustment categories that reflect levels of nearly homogenous resource utilization by ACG assignment; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(a)(iii)">(iii)</span> Assign an enrollee to a risk adjustment category (RAC) based upon the enrollee's ACG assignment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(b)">(b)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(2)(c)" title="">§B(2)(c) of this regulation</a>, for enrollees for whom the Department has insufficient data to generate an ACG assignment, the Department shall assign the enrollee to a risk adjustment category that reflects the enrollee's age, residence, and gender; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(c)">(c)</span> On the basis of the enrollee's residence, the Department shall assign:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(c)(i)">(i)</span> Enrollees with HIV to one of the two HIV payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">§B(4)(b) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(2)(c)(ii)">(ii)</span> Enrollees with AIDS to one of the two AIDS payment categories set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">§B(4)(b) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(3)">(3)</span> Supplemental Delivery/Newborn Payments.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(3)(a)">(a)</span> In addition to the monthly payment specified in §B(4)(a) or (b) of this regulation for an enrollee's payment category, the Department shall pay an MCO one supplemental payment per pregnancy in the amount specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(c)" title="">§B(4)(c) of this regulation</a>, upon delivery of one or more infants without regard to method, timing, or place of delivery.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(3)(b)">(b)</span> An MCO shall have 12 months from the date of delivery to bill for the supplemental payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)">(4)</span> Except to the extent of adjustments required by <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D" title="">§D of this regulation</a> or by Regulations .19-1 through 19-3 of this chapter, the Department shall make payments monthly at the rates specified in the following tables:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(a)">(a)</span> Rate Table for Families and Children Effective January 1, 2020—December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-text-align="center">Under age 1 Birth Weight 1500 grams or less</td>
                        <td data-text-align="center">Both</td>
                        <td data-text-align="center">$10,545.89</td>
                        <td data-text-align="center">$9,424.40</td>
                        <td data-text-align="center">$9,791.62</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">Under age 1 Birth Weight over 1500 grams</td>
                        <td data-text-align="center" data-vertical-align="middle">Both</td>
                        <td data-text-align="center" data-vertical-align="middle">$540.93</td>
                        <td data-text-align="center" data-vertical-align="middle">$483.41</td>
                        <td data-text-align="center" data-vertical-align="middle">$502.25</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$212.56</td>
                        <td data-vertical-align="middle">$189.96</td>
                        <td data-vertical-align="middle">$197.36</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$179.94</td>
                        <td data-vertical-align="middle">$160.82</td>
                        <td data-vertical-align="middle">$167.07</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$128.11</td>
                        <td data-vertical-align="middle">$114.49</td>
                        <td data-vertical-align="middle">$118.95</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$130.65</td>
                        <td data-vertical-align="middle">$116.76</td>
                        <td data-vertical-align="middle">$121.31</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$156.36</td>
                        <td data-vertical-align="middle">$139.73</td>
                        <td data-vertical-align="middle">$145.18</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$200.42</td>
                        <td data-vertical-align="middle">$179.11</td>
                        <td data-vertical-align="middle">$186.09</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$313.97</td>
                        <td data-vertical-align="middle">$244.47</td>
                        <td data-vertical-align="middle">$259.96</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$423.37</td>
                        <td data-vertical-align="middle">$329.65</td>
                        <td data-vertical-align="middle">$350.54</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$649.86</td>
                        <td data-vertical-align="middle">$506.01</td>
                        <td data-vertical-align="middle">$538.07</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$710.21</td>
                        <td data-vertical-align="middle">$552.99</td>
                        <td data-vertical-align="middle">$588.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2800, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3800, 4210, 5100, 5110, 5200 5230, 5310, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$246.88</td>
                        <td data-vertical-align="middle">$192.23</td>
                        <td data-vertical-align="middle">$204.41</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4610, 4710, 4720, 4810, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$404.93</td>
                        <td data-vertical-align="middle">$315.29</td>
                        <td data-vertical-align="middle">$335.27</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$541.50</td>
                        <td data-vertical-align="middle">$421.63</td>
                        <td data-vertical-align="middle">$448.35</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$765.47</td>
                        <td data-vertical-align="middle">$596.02</td>
                        <td data-vertical-align="middle">$633.79</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930, 5030, 5050</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,093.51</td>
                        <td data-vertical-align="middle">$851.45</td>
                        <td data-vertical-align="middle">$905.40</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5060</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,395.82</td>
                        <td data-vertical-align="middle">$1,086.83</td>
                        <td data-vertical-align="middle">$1,155.70</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,384.13</td>
                        <td data-vertical-align="middle">$1,856.36</td>
                        <td data-vertical-align="middle">$1,973.99</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 500, 600, 1100, 1600, 2000, 2400, 3400, 5100, 5110, 5200</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$95.15</td>
                        <td data-vertical-align="middle">$85.03</td>
                        <td data-vertical-align="middle">$88.34</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 700, 900, 1000, 1200, 1300, 1710, 1711, 1712, 1800, 1900, 2100, 2200, 2300, 2800, 2900, 3000, 3100, 5310</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$120.44</td>
                        <td data-vertical-align="middle">$107.63</td>
                        <td data-vertical-align="middle">$111.83</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1720, 1721, 1722, 1731, 1732, 1730, 2500, 3200, 3300, 3500, 3800, 4210, 5230, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$155.94</td>
                        <td data-vertical-align="middle">$139.35</td>
                        <td data-vertical-align="middle">$144.78</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4610, 4710, 4720, 4810, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$216.35</td>
                        <td data-vertical-align="middle">$193.34</td>
                        <td data-vertical-align="middle">$200.87</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$333.86</td>
                        <td data-vertical-align="middle">$298.36</td>
                        <td data-vertical-align="middle">$309.98</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$412.16</td>
                        <td data-vertical-align="middle">$368.33</td>
                        <td data-vertical-align="middle">$382.68</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930,4940, 5030, 5050, 5060, 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,171.43</td>
                        <td data-vertical-align="middle">$1,046.85</td>
                        <td data-vertical-align="middle">$1,087.64</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">SOBRA Mothers</td>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">$782.58</td>
                        <td data-vertical-align="middle">$609.35</td>
                        <td data-vertical-align="middle">$647.96</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-text-align="center" data-vertical-align="middle">ALL</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,468.70</td>
                        <td data-vertical-align="middle">$2,468.70</td>
                        <td data-vertical-align="middle">$2,468.70</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(b)">(b)</span> Rate Table for Disabled Individuals Effective January 1, 2020— December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM <br/>Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">Under Age 1</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$8,185.50</td>
                        <td data-vertical-align="middle">$8,185.50</td>
                        <td data-vertical-align="middle">$8,185.50</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$1,118.79</td>
                        <td data-vertical-align="middle">$1,118.79</td>
                        <td data-vertical-align="middle">$1,118.79</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$1,494.58</td>
                        <td data-vertical-align="middle">$1,494.58</td>
                        <td data-vertical-align="middle">$1,494.58</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$250.31</td>
                        <td data-vertical-align="middle">$250.31</td>
                        <td data-vertical-align="middle">$250.31</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$489.01</td>
                        <td data-vertical-align="middle">$489.01</td>
                        <td data-vertical-align="middle">$489.01</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$257.52</td>
                        <td data-vertical-align="middle">$257.72</td>
                        <td data-vertical-align="middle">$257.52</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$315.55</td>
                        <td data-vertical-align="middle">$315.55</td>
                        <td data-vertical-align="middle">$315.55</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$837.74</td>
                        <td data-vertical-align="middle">$685.54</td>
                        <td data-vertical-align="middle">$717.57</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$829.48</td>
                        <td data-vertical-align="middle">$678.78</td>
                        <td data-vertical-align="middle">$710.49</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$2,287.81</td>
                        <td data-vertical-align="middle">$1,872.16</td>
                        <td data-vertical-align="middle">$959.63</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$2,675.35</td>
                        <td data-vertical-align="middle">$2,189.29</td>
                        <td data-vertical-align="middle">$2,291.58</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 1100, 1300, 1400, 1500, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1900, 2400, 2600, 2900, 3400, 5100, 5110, 5200, 5310</td>
                        <td data-vertical-align="middle">RAC 10</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$327.55</td>
                        <td data-vertical-align="middle">$268.04</td>
                        <td data-vertical-align="middle">$280.57</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 500, 700, 900, 1000, 1200, 1740, 1741, 1742, 1750, 1751, 1752 1800, 2000, 2100, 2200, 2300, 2500, 2700, 2800, 3000, 3100, 3200, 3300, 3500, 3900, 4000, 4310, 5330</td>
                        <td data-vertical-align="middle">RAC 11</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$354.27</td>
                        <td data-vertical-align="middle">$289.90</td>
                        <td data-vertical-align="middle">$303.45</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 600, 1760, 1761, 1762, 3600, 3700, 4100, 4320, 4410, 4710, 4810, 4820</td>
                        <td data-vertical-align="middle">RAC 12</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$691.31</td>
                        <td data-vertical-align="middle">$565.71</td>
                        <td data-vertical-align="middle">$592.15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 3800, 4210, 4220, 4330, 4420, 4720, 4910, 5320</td>
                        <td data-vertical-align="middle">RAC 13</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$810.19</td>
                        <td data-vertical-align="middle">$662.99</td>
                        <td data-vertical-align="middle">$693.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 4430, 4510, 4610, 5040, 5340</td>
                        <td data-vertical-align="middle">RAC 14</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,071.43</td>
                        <td data-vertical-align="middle">$876.77</td>
                        <td data-vertical-align="middle">$917.74</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1770, 1771, 1772, 4520, 4620, 4830, 4920, 5050</td>
                        <td data-vertical-align="middle">RAC 15</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,487.90</td>
                        <td data-vertical-align="middle">$1,217.58</td>
                        <td data-vertical-align="middle">$1,274.74</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4730, 4930, 5010</td>
                        <td data-vertical-align="middle">RAC 16</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,510.41</td>
                        <td data-vertical-align="middle">$1,235.99</td>
                        <td data-vertical-align="middle">$1,293.74</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5020, 5060</td>
                        <td data-vertical-align="middle">RAC 17</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,208.93</td>
                        <td data-vertical-align="middle">$1,807.61</td>
                        <td data-vertical-align="middle">$1,892.07</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5030, 5070</td>
                        <td data-vertical-align="middle">RAC 18</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,013.13</td>
                        <td data-vertical-align="middle">$3,284.02</td>
                        <td data-vertical-align="middle">$3,437.46</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with AIDS</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,968.09</td>
                        <td data-vertical-align="middle">$3,504.83</td>
                        <td data-vertical-align="middle">$3,504.83</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,255.37</td>
                        <td data-vertical-align="middle">$4,255.37</td>
                        <td data-vertical-align="middle">$4,255.37</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(c)">(c)</span> Rate Table for Supplemental Payments for Delivery/Newborn and Hepatitis C Therapy Effective January 1, 2020  December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM<br/> Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Supplemental Payment Cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn-all births except live birth weight 1,500 grams or less and gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,039.19</td>
                        <td data-vertical-align="middle">$13,490.76</td>
                        <td data-vertical-align="middle">$14,736.04</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn - live birth weight 1,500 grams or less and a gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$86,856.32</td>
                        <td data-vertical-align="middle">$86,856.32</td>
                        <td data-vertical-align="middle">$86,856.32</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn by same enrollee - subsequent live birth weight 1,500 grams or less with a gestational age less than 21 weeks or does not meet the requirements in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(i)" title="">§B(4)(i) of this regulation</a></td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,039.19</td>
                        <td data-vertical-align="middle">$13,490.76</td>
                        <td data-vertical-align="middle">$14,736.04</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Hepatitis C Therapy</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$15,662.46</td>
                        <td data-vertical-align="middle">$15,662.46</td>
                        <td data-vertical-align="middle">$15,662.46</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(d)">(d)</span> Rate Table for Childless Adult Population Effective January 1, 2020—December 31, 2020.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$389.33</td>
                        <td data-vertical-align="middle">$295.91</td>
                        <td data-vertical-align="middle">$342.16</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$476.88</td>
                        <td data-vertical-align="middle">$361.99</td>
                        <td data-vertical-align="middle">$418.56</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$1,069.91</td>
                        <td data-vertical-align="middle">$812.15</td>
                        <td data-vertical-align="middle">$939.07</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$1,039.04</td>
                        <td data-vertical-align="middle">$788.71</td>
                        <td data-vertical-align="middle">$911.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2800, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3800, 4210, 5100, 5110, 5200 5230, 5310, 5339</td>
                        <td data-vertical-align="middle">RAC 1H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$282.42</td>
                        <td data-vertical-align="middle">$247.88</td>
                        <td data-vertical-align="middle">$280.81</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4610, 4710, 4720, 4810, 5340</td>
                        <td data-vertical-align="middle">RAC 2H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$471.76</td>
                        <td data-vertical-align="middle">$414.07</td>
                        <td data-vertical-align="middle">$422.55</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820</td>
                        <td data-vertical-align="middle">RAC 3H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$489.23</td>
                        <td data-vertical-align="middle">$429.40</td>
                        <td data-vertical-align="middle">$439.99</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-vertical-align="middle">RAC 4H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$899.28</td>
                        <td data-vertical-align="middle">$789.30</td>
                        <td data-vertical-align="middle">$763.22</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930, 5030, 5050</td>
                        <td data-vertical-align="middle">RAC 5H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,155.28</td>
                        <td data-vertical-align="middle">$1,014.00</td>
                        <td data-vertical-align="middle">$955.15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5060</td>
                        <td data-vertical-align="middle">RAC 6H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,639.97</td>
                        <td data-vertical-align="middle">$1,439.41</td>
                        <td data-vertical-align="middle">$1,234.70</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-vertical-align="middle">RAC 7H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,477.09</td>
                        <td data-vertical-align="middle">$1,880.29</td>
                        <td data-vertical-align="middle">$2,174.15</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">HIV</td>
                        <td data-vertical-align="middle">19â64</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,991.40</td>
                        <td data-vertical-align="middle">$2,991.40</td>
                        <td data-vertical-align="middle">$2,991.40</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(e)">(e)</span> Rate Table for Families and Children Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">Under age 1 Birth Weight 1500 grams or less</td>
                        <td data-text-align="center" data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$10,801.56</td>
                        <td data-vertical-align="middle">$10,084.05</td>
                        <td data-vertical-align="middle">$10,367.99</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">Under age 1 Birth Weight over 1500 grams</td>
                        <td data-text-align="center" data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$531.06</td>
                        <td data-vertical-align="middle">$498.78</td>
                        <td data-vertical-align="middle">$509.74</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$213.82</td>
                        <td data-vertical-align="middle">$199.61</td>
                        <td data-vertical-align="middle">$205.23</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$176.22</td>
                        <td data-vertical-align="middle">$164.52</td>
                        <td data-vertical-align="middle">$169.15</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$112.91</td>
                        <td data-vertical-align="middle">$105.41</td>
                        <td data-vertical-align="middle">$108.37</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$106.03</td>
                        <td data-vertical-align="middle">$98.98</td>
                        <td data-vertical-align="middle">$101.77</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$188.76</td>
                        <td data-vertical-align="middle">$176.22</td>
                        <td data-vertical-align="middle">$181.18</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$185.28</td>
                        <td data-vertical-align="middle">$172.97</td>
                        <td data-vertical-align="middle">$177.84</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$296.27</td>
                        <td data-vertical-align="middle">$238.54</td>
                        <td data-vertical-align="middle">$256.08</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$410.17</td>
                        <td data-vertical-align="middle">$330.24</td>
                        <td data-vertical-align="middle">$354.54</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-text-align="center" data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$727.80</td>
                        <td data-vertical-align="middle">$585.98</td>
                        <td data-vertical-align="middle">$629.09</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$681.00</td>
                        <td data-vertical-align="middle">$548.30</td>
                        <td data-vertical-align="middle">$588.63</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1400, 1500 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1741, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2600, 2700, 2800, 2900, 3000, 3100, 3200, 3300, 3900, 3400, 3500, 3800, 4210, 4610, 5100, 5110, 5200 5230, 5310, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$207.12</td>
                        <td data-vertical-align="middle">$166.76</td>
                        <td data-vertical-align="middle">$179.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1740, 1741, 1742, 1750, 2700, 3600, 1732, 1750, 1751, 1752, 1761, 2700, 3200, 3300, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4320, 4410, 4510, 4610, 4620, 4710, 4720, 4810, 5010, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$373.28</td>
                        <td data-vertical-align="middle">$300.54</td>
                        <td data-vertical-align="middle">$322.65</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4330, 4520, 4620, 4730, 4810, 4820,4910, 5020</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$571.66</td>
                        <td data-vertical-align="middle">$494.12</td>
                        <td data-vertical-align="middle">$460.27</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 1772, 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$735.65</td>
                        <td data-vertical-align="middle">$592.31</td>
                        <td data-vertical-align="middle">$635.87</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4920, 4930, 5030, 5050</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,044.18</td>
                        <td data-vertical-align="middle">$840.70</td>
                        <td data-vertical-align="middle">$902.55</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5030,5060</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,428.81</td>
                        <td data-vertical-align="middle">$1,150.40</td>
                        <td data-vertical-align="middle">$1,235.01</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7F</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,469.99</td>
                        <td data-vertical-align="middle">$1,988.70</td>
                        <td data-vertical-align="middle">$2,134.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 500, 600, 0400, 0900, 1100, 1300, 1600, 2000, 2400, 3400, 3900, 4000, 4100, 5100, 5110, 5200</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 1G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$78.17</td>
                        <td data-vertical-align="middle">$72.97</td>
                        <td data-vertical-align="middle">$75.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 700, 900, 0100, 1000, 1200, 1300, 1400, 1500, 1710, 1711, 1712, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2600, 2800, 2900, 3000, 3100, 3400, 3500, 5310, 5321</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 2G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$109.00</td>
                        <td data-vertical-align="middle">$101.76</td>
                        <td data-vertical-align="middle">$104.63</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1200, 1711, 1712, 1720, 1721, 1722, 1731, 1732, 1730, 2500, 2700, 2900, 3200, 3300, 3500, 3600, 3700, 3800, 4210, 5230, 5311, 5339</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 3G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$152.99</td>
                        <td data-vertical-align="middle">$142.83</td>
                        <td data-vertical-align="middle">$146.85</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1721, 1722, 1740, 1741, 1742, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4410, 4510, 4520, 4610, 4710, 4720, 4810, 4332, 5340</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 4G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$221.94</td>
                        <td data-vertical-align="middle">$207.20</td>
                        <td data-vertical-align="middle">$213.03</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500,1731, 1732, 1741, 1750, 1751, 1761, 1762, 1770, 1771, 1772, 2600, 4320, 4520, 4620, 4820, 5010</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 5G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$381.05</td>
                        <td data-vertical-align="middle">$355.74</td>
                        <td data-vertical-align="middle">$365.76</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 1771, 1772, 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 6G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$443.16</td>
                        <td data-vertical-align="middle">$413.72</td>
                        <td data-vertical-align="middle">$425.37</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4930,4940, 5030, 5050, 5060, 5070</td>
                        <td data-text-align="center" data-vertical-align="middle">RAC 7G</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,167.92</td>
                        <td data-vertical-align="middle">$1,090.34</td>
                        <td data-vertical-align="middle">$1,121.04</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">SOBRA Mothers</td>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">$756.99</td>
                        <td data-vertical-align="middle">$609.48</td>
                        <td data-vertical-align="middle">$654.31</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-text-align="center" data-vertical-align="middle">ALL</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,772.07</td>
                        <td data-vertical-align="middle">$2,772.07</td>
                        <td data-vertical-align="middle">$2,772.07</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(f)">(f)</span> Rate Table for Disabled Individuals Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">Under Age 1</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$7,421.87</td>
                        <td data-vertical-align="middle">$7,421.87</td>
                        <td data-vertical-align="middle">$7,421.87</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">15</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$2,326.06</td>
                        <td data-vertical-align="middle">$2,326.06</td>
                        <td data-vertical-align="middle">$2,326.06</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$919.92</td>
                        <td data-vertical-align="middle">$919.92</td>
                        <td data-vertical-align="middle">$919.92</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">614</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$185.04</td>
                        <td data-vertical-align="middle">$185.04</td>
                        <td data-vertical-align="middle">$185.04</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$336.06</td>
                        <td data-vertical-align="middle">$336.06</td>
                        <td data-vertical-align="middle">$336.06</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1520</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$158.42</td>
                        <td data-vertical-align="middle">$158.42</td>
                        <td data-vertical-align="middle">$158.42</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$277.79</td>
                        <td data-vertical-align="middle">$277.79</td>
                        <td data-vertical-align="middle">$277.79</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">2144</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$721.14</td>
                        <td data-vertical-align="middle">$592.87</td>
                        <td data-vertical-align="middle">$649.45</td>
                      </tr>
                      <tr>
                        <td/>
                        <td/>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$789.07</td>
                        <td data-vertical-align="middle">$648.18</td>
                        <td data-vertical-align="middle">$710.04</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$2,317.01</td>
                        <td data-vertical-align="middle">$1,903.30</td>
                        <td data-vertical-align="middle">$2,084.95</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$2,708.00</td>
                        <td data-vertical-align="middle">$2,224.47</td>
                        <td data-vertical-align="middle">$2,436.77</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 0500, 0600, 0700, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1741, 1900, 2000, 2100, 2200, 2400, 2500, 2600, 2700, 2900, 3400, 3500, 3800, 5100, 5110, 5200, 5310, 5331</td>
                        <td data-vertical-align="middle">RAC 10</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$244.87</td>
                        <td data-vertical-align="middle">$201.15</td>
                        <td data-vertical-align="middle">$220.35</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 400, 500, 700, 900, 0300, 1000, 1400, 1200, 1712, 1732, 1740, 1741, 1742, 1750, 1751, 1752 1800, 1900, 2000, 2100, 2200, 2300, 2500, 2700, 2800, 3000, 3100, 3200, 3300, 3500, 3700, 3900, 4000, 4210, 4310, 4510, 4610, 4710, 5312, 5330</td>
                        <td data-vertical-align="middle">RAC 11</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$324.66</td>
                        <td data-vertical-align="middle">$266.89</td>
                        <td data-vertical-align="middle">$292.14</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 600, 0100, 1721, 1751, 1752, 1760, 1761, 1762, 2900, 3600, 3700, 4100, 4220, 4320, 4330, 4410, 4710, 4720, 4810, 4820, 5010, 5322</td>
                        <td data-vertical-align="middle">RAC 12</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$575.63</td>
                        <td data-vertical-align="middle">$472.85</td>
                        <td data-vertical-align="middle">$517.98</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 3800, 4100, 4210, 4220, 4330, 4410, 4420, 4520, 4620, 4720, 4730, 4820, 4910, 5020, 5320</td>
                        <td data-vertical-align="middle">RAC 13</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$815.35</td>
                        <td data-vertical-align="middle">$699.76</td>
                        <td data-vertical-align="middle">$733.69</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 1771, 4420, 4430, 4510, 4610, 4830, 4910, 5040, 5332, 5340</td>
                        <td data-vertical-align="middle">RAC 14</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,152.30</td>
                        <td data-vertical-align="middle">$946.55</td>
                        <td data-vertical-align="middle">$1,036.89</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1770, 1771, 1772, 4430, 4520, 4620, 4830, 4920, 5050</td>
                        <td data-vertical-align="middle">RAC 15</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,527.61</td>
                        <td data-vertical-align="middle">$1,254.85</td>
                        <td data-vertical-align="middle">$1,374.61</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 4730, 4930, 5010, 5050</td>
                        <td data-vertical-align="middle">RAC 16</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,483.61</td>
                        <td data-vertical-align="middle">$1,465.14</td>
                        <td data-vertical-align="middle">$1,604.97</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4940, 5020, 5060</td>
                        <td data-vertical-align="middle">RAC 17</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,371.86</td>
                        <td data-vertical-align="middle">$1,948.35</td>
                        <td data-vertical-align="middle">$2,134.30</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5030, 5070, 5342</td>
                        <td data-vertical-align="middle">RAC 18</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$3,991.27</td>
                        <td data-vertical-align="middle">$3,278.61</td>
                        <td data-vertical-align="middle">$3,591.52</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with AIDS</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$5,003.30</td>
                        <td data-vertical-align="middle">$3,607.01</td>
                        <td data-vertical-align="middle">$3,607.01</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Persons with HIV</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$4,554.33</td>
                        <td data-vertical-align="middle">$4,554.33</td>
                        <td data-vertical-align="middle">$4,554.33</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(g)">(g)</span> Rate Table for Supplemental Payments for Delivery/Newborn and Hepatitis C Therapy Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Age/RAC</th>
                        <th>Gender</th>
                        <th>PMPM Baltimore City</th>
                        <th>PMPM Montgomery County</th>
                        <th>PMPM Rest of State</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">Supplemental Payment Cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn-all births except live birth weight 1,500 grams or less and gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,278.93</td>
                        <td data-vertical-align="middle">$12,566.25</td>
                        <td data-vertical-align="middle">$14,733.72</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn - live birth weight 1,500 grams or less and a gestational age of 21 weeks or more</td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$93,700.08</td>
                        <td data-vertical-align="middle">$93,700.08</td>
                        <td data-vertical-align="middle">$93,700.08</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">Delivery/Newborn by same enrollee - subsequent live birth weight 1,500 grams or less with a gestational age less than 21 weeks or does not meet the requirements in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(i)" title="">§B(4)(i) of this regulation</a></td>
                        <td data-vertical-align="middle">All</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$17,278.93</td>
                        <td data-vertical-align="middle">$12,566.25</td>
                        <td data-vertical-align="middle">$14,733.72</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(h)">(h)</span> Rate Table for Childless Adult Population Effective January 1, 2021—December 31, 2021.</p>
                <div class="table_wrap">
                  <table>
                    <tbody>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">Age/RAC</td>
                        <td data-vertical-align="middle">Gender</td>
                        <td data-vertical-align="middle">PMPM Baltimore City</td>
                        <td data-vertical-align="middle">PMPM Montgomery County</td>
                        <td data-vertical-align="middle">PMPM Rest of State</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$405.20</td>
                        <td data-vertical-align="middle">$315.63</td>
                        <td data-vertical-align="middle">$346.25</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">1944</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$484.26</td>
                        <td data-vertical-align="middle">$377.21</td>
                        <td data-vertical-align="middle">$413.81</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Male</td>
                        <td data-vertical-align="middle">$1,142.43</td>
                        <td data-vertical-align="middle">$889.88</td>
                        <td data-vertical-align="middle">$976.21</td>
                      </tr>
                      <tr>
                        <td/>
                        <td data-vertical-align="middle">4564</td>
                        <td data-vertical-align="middle">Female</td>
                        <td data-vertical-align="middle">$1,144.65</td>
                        <td data-vertical-align="middle">$891.61</td>
                        <td data-vertical-align="middle">$978.11</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG-adjusted cells</td>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 100, 200, 300, 400, 500, 600, 700, 900, 1000, 1100, 1200, 1300, 1500, 1600, 1710, 1711, 1712, 1720, 1721, 1722, 1730, 1731, 1732, 1741, 1742, 1752, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2700, 2800, 2900, 3000, 3100, 3200, 3300, 3400, 3500, 3800, 3900, 4000, 4210, 4310, 4510, 4710, 5100, 5110, 5200, 5230, 5310, 5339</td>
                        <td data-vertical-align="middle">RAC 1H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$248.20</td>
                        <td data-vertical-align="middle">$193.33</td>
                        <td data-vertical-align="middle">$212.09</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 800, 0900, 1000, 1400, 1731, 1740, 1741, 1742, 1750, 1761, 1762, 2300, 2600, 2700, 3600, 1750, 1751, 1752, 2700, 3600, 3700, 3900, 4000, 4100, 4220, 4310, 4320, 4410, 4510, 4610, 4710, 4720, 4810, 4820, 5340</td>
                        <td data-vertical-align="middle">RAC 2H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$454.46</td>
                        <td data-vertical-align="middle">$353.99</td>
                        <td data-vertical-align="middle">$388.34</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 1400, 1500, 1711, 1750, 1761, 1762, 1770, 1771, 1772, 2600, 4100, 4320, 4330, 4410, 4520, 4620, 4730, 4820, 5010, 5020</td>
                        <td data-vertical-align="middle">RAC 3H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$583.20</td>
                        <td data-vertical-align="middle">$454.27</td>
                        <td data-vertical-align="middle">$498.34</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 0800, 1751, 1772, 4330, 4420, 4830, 4910, 4920, 5010, 5020, 5040</td>
                        <td data-vertical-align="middle">RAC 4H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$863.24</td>
                        <td data-vertical-align="middle">$672.41</td>
                        <td data-vertical-align="middle">$737.65</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4430, 4730, 4920, 4930, 5030, 5050</td>
                        <td data-vertical-align="middle">RAC 5H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,249.46</td>
                        <td data-vertical-align="middle">$973.25</td>
                        <td data-vertical-align="middle">$1,067.68</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 4930, 4940, 5060</td>
                        <td data-vertical-align="middle">RAC 6H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$1,680.86</td>
                        <td data-vertical-align="middle">$1,309.28</td>
                        <td data-vertical-align="middle">$1,436.31</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">ACG 5070</td>
                        <td data-vertical-align="middle">RAC 7H</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$2,579.16</td>
                        <td data-vertical-align="middle">$2,009.00</td>
                        <td data-vertical-align="middle">$2,203.91</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">HIV</td>
                        <td data-vertical-align="middle">19â64</td>
                        <td data-vertical-align="middle">Both</td>
                        <td data-vertical-align="middle">$3,135.78</td>
                        <td data-vertical-align="middle">$3,135.78</td>
                        <td data-vertical-align="middle">$3,135.78</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)">(i)</span> Interpretation of Rate Table for Families and Children. The table found at <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">§B(4)(a) of this regulation</a> shows capitation rates for individuals who are:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(i)">(i)</span> Waiver eligible based on receipt of benefits through TCA or programs for medically needy families and children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(ii)">(ii)</span> SOBRA children;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(iii)">(iii)</span> SOBRA mothers; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(i)(iv)">(iv)</span> The Maryland Children's Health Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(j)">(j)</span> Interpretation of Rate Table for Disabled Individuals. The table found at <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(b)" title="">§B(4)(b) of this regulation</a> shows the capitation rates for individuals who are waiver-eligible based upon receipt of benefits through SSI or as medically needy, aged, blind, or disabled.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(k)">(k)</span> Interpretation of Rate Table for Supplemental Payment for Delivery/Newborn. The table found at <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)(c)" title="">§B(4)(c) of this regulation</a> shows a supplemental payment made in connection with deliveries of MCO enrollees, regardless of the enrollee's payment category under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.19#B(4)(a)" title="">COMAR 10.67.04.19B(4)(a)</a> or (b).</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(4)(l)">(l)</span> Interpretation of Rate Tables in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">§B(4) of this regulation</a>. "PMPM" means the per member per month payment rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#B(5)">(5)</span> Consistent with the terms set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4" title=".19-4 MCO Medical Loss Ratio.">Regulation .19-4 of this chapter</a>, the Department may, in consultation with the Commissioner, adjust the capitation payment of an MCO if it determines that the MCO's loss ratio, not including any rebate received by the MCO is less than 85 percent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#C">C.</span> The Department shall reimburse fee-for-service:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#C(1)">(1)</span> The Departmental share for any enrollee participating in the Stop Loss Program pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.22" title=".22 Stop Loss Program.">Regulation .22 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#C(2)">(2)</span> The cost of those services specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.69.06" title=".06 Requirements for Provider Qualification.">COMAR 10.09.69.06</a>.13 provided to the participant that have been authorized by the participant's case manager in accordance with the participant's plan of care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D">D.</span> Interim Rates Adjustments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(1)">(1)</span> Under the circumstances described in §D(2) and (3) of this regulation, the Department shall adjust the capitation rates set forth in §B(4)(a), (b), (e), and (f) of this regulation to reflect changes in service costs during the contract year due to an occurrence listed in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)" title="">§D(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)">(2)</span> The Department shall adjust the payment rates specified in §B(4)(a)(h) of this regulation to reflect service cost changes that qualify under <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(3)" title="">§D(3) of this regulation</a> and result from:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(a)">(a)</span> An addition or deletion of services covered under the HealthChoice benefits package;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(b)">(b)</span> An increase or decrease in Medicaid fee-for-service payment rates or copayments, if the MCOs are obligated to adjust their payment rates to providers as a result of those fee-for-service rate changes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(c)">(c)</span> An increase or decrease in the inpatient charge per case as calculated by the change in the restated unit cost provided annually by the HSCRC as compared to the data originally provided; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(2)(d)">(d)</span> An increase or decrease in the outpatient charge per visit as calculated by the change in the restated unit cost provided annually by the HSCRC as compared to the data originally provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(3)">(3)</span> The Department shall make an interim rates adjustment if the effect of an occurrence listed in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)" title="">§D(2) of this regulation</a> is sufficient to result in program-wide overpayment or underpayment of at least 0.2 percent because of the difference between:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(3)(a)">(a)</span> Service cost projections used to develop the rates set forth in §B(4)(a), (b), (e), and (f) of this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(3)(b)">(b)</span> Service costs for the same period, taking into account an occurrence that is listed in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)" title="">§D(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(4)">(4)</span> The Department shall make any interim rate adjustments required by this section in amounts that are proportionate to the overpayments or underpayments described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(3)" title="">§D(3) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(5)">(5)</span> Provider rate adjustments as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#D(2)(b)" title="">§D(2)(b) of this regulation</a> may not require the MCOs to pay providers more than the Medicaid fee-for-service rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(6)">(6)</span> The Department shall make supplemental payments to an MCO that reflect increases in MCO provider payments for trauma services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.25.10" title="Chapter 10 Maryland Trauma Physician Services Fund">COMAR 10.25.10</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#D(7)">(7)</span> The Department shall make an interim rates adjustment in Calendar Years 2022, 2023, 2024, and 2025 to account for changes in acuity due to alterations in redetermination and enrollment processes related to COVID-19.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E">E.</span> Interim Rate Adjustment for Calendar Year 2025.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)">(1)</span> The Department shall re-open the capitation rates for interim rate adjustments in Calendar Year 2025 to revisit the following adjustments:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(a)">(a)</span> Risk adjustment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(b)">(b)</span> Trend;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(c)">(c)</span> Administration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(d)">(d)</span> Regional factors; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(1)(e)">(e)</span> Relational modeling.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19#E(2)">(2)</span> To assist with the assessment, MCOs shall provide additional information to the Department upon request, including detailed claims data as well as a year-to-date HealthChoice Financial Monitoring Report for the calendar year.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.19-1" data-order="|10|67|04|.19-1|" data-ref-path="10|67|04|.19-1" class="h__section">.19-1 MCO-Specific Case Mix Adjustment for HIV and AIDS with Hepatitis C.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#A">A.</span> To reflect the higher level of risk associated with providing covered health care services pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a> to HIV/AIDS enrollees who also have Hepatitis C, the Department shall, to the extent provided by this regulation, make MCO-specific adjustments to payments for enrollees in HIV and AIDS payment categories to reflect the proportion of an MCO's HIV/AIDS enrollees who also have Hepatitis C.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B">B.</span> Identification of HIV/AIDS Enrollees with Hepatitis C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(1)">(1)</span> For each MCO, the Department shall consider historical encounter and fee-for-service data for enrollees assigned to HIV and AIDS payment categories:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(1)(a)">(a)</span> For the initial assessment period, as of June of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(1)(b)">(b)</span> For the mid-year assessment period, as of December of the calendar year before the rate year.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(2)">(2)</span> For each MCO, the Department shall determine which of the HIV/AIDS enrollees meeting the criteria set forth in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#B(1)" title="">§B(1) of this regulation</a> also have Hepatitis C.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(3)">(3)</span> The Department shall use encounter and fee-for-service data documenting services provided to the HIV/AIDS enrollees identified in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#B(1)" title="">§B(1) of this regulation</a> for the appropriate historical diagnostic period:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(3)(a)">(a)</span> For the initial assessment period, through June of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#B(3)(b)">(b)</span> For the mid-year assessment period, through December of the calendar year before the rate year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C">C.</span> Methodology for Determining MCO-specific HIV and AIDS Case Mix Measures. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(1)">(1)</span> Based on encounter and fee-for-service data from the appropriate historical diagnostic period, classify the MCO's HIV/AIDS enrollees identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#B" title="">§B of this regulation</a> as either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(1)(a)">(a)</span> Hepatitis C-infected; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(1)(b)">(b)</span> Hepatitis C-uninfected.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(2)">(2)</span> Average relative value for HIV and AIDS payment categories are as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(2)(a)">(a)</span> Apply weights reflecting costs associated with Hepatitis C-infected and Hepatitis C-uninfected enrollees in each HIV and AIDS payment category to the MCO-specific distribution of HIV/AIDS enrollees who are Hepatitis C-infected or Hepatitis C-uninfected, as determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(1)" title="">§C(1) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(2)(b)">(b)</span> For each MCO, use the results of the calculations specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(2)(a)" title="">§C(2)(a) of this regulation</a> to separately calculate an average relative value for each of the HIV and AIDS payment categories.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#C(3)">(3)</span> To determine an MCO's relative case mix factors, each MCO's relative values determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(2)(b)" title="">§C(2)(b) of this regulation</a> are divided by the overall average relative value determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(2)(a)" title="">§C(2)(a) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D">D.</span> Methodology for MCO-Specific Case Mix-Adjusted HIV and AIDS Rates. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D(1)">(1)</span> Calculate MCO-specific HIV and AIDS relative case mix factors for each HIV and AIDS payment group pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#C(3)" title="">§C(3) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D(2)">(2)</span> Calculate MCO-specific HIV and AIDS rates for the rate adjustment period by multiplying the risk adjustment factor derived pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#D(1)" title="">§D(1) of this regulation</a> by the value specified for each HIV and AIDS payment group for the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#D(3)">(3)</span> Apply a budget neutrality adjustment to the values derived pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#D(2)" title="">§D(2) of this regulation</a> so that the aggregate of payments to all MCOs pursuant to this regulation are equivalent to the aggregate of all payments that would be due to all MCOs in the absence of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E">E.</span> Case Mix Updates. The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(1)">(1)</span> Update current enrollees' region of residence and enrollment categories by repeating the calculations in §§B—D of this regulation every 6 months using residence and enrollment data as of the enrollment month specified below:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(1)(a)">(a)</span> For the initial assessment period of each rate year, June of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(1)(b)">(b)</span> For the mid-year assessment period of each rate year, December of the calendar year before the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-1#E(2)">(2)</span> For rate adjustment periods beginning January 1 and July 1 of each rate year, use each MCO's updated Hepatitis C-infected and Hepatitis C-uninfected distribution to compute its risk adjusted HIV and AIDS payment rates for each rate adjustment period, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-1#D" title="">§D of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.19-2" data-order="|10|67|04|.19-2|" data-ref-path="10|67|04|.19-2" class="h__section">.19-2 MCO Supplemental Payment for Transitional Encounter Data Adjustment.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-2#A">A.</span> The Department may grant an adjustment to those MCOs for whom the uniform encounter data adjustment results in completeness factors that are below the Statewide average.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-2#B">B.</span> The encounter adjustment for each MCO shall be determined for the Family and Children RACs and for the Disabled RACs respectively.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.19-3" data-order="|10|67|04|.19-3|" data-ref-path="10|67|04|.19-3" class="h__section">.19-3 MCO-Specific Case Mix Adjustment.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A">A.</span> Definitions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(1)">(1)</span> In this regulation, in addition to the definitions set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.01" title="Chapter 01 Maryland Medicaid Managed Care Program: Definitions">COMAR 10.67.01</a>, the following terms have the meanings indicated.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)">(2)</span> Terms Defined.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(a)">(a)</span> "Demographic rate cell" means a cell in one of the rates tables in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">Regulation .19B(4) of this chapter</a> to which an MCO's enrollees are assigned pursuant to Regulation .19B(1)(b) and B(2)(b) of this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(b)">(b)</span> "Initial rate adjustment period" means the 6-month period beginning January 1 of the rate year.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(c)">(c)</span> "Mid-year rate adjustment period" means the 6-month period beginning July 1 of the rate year.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(d)">(d)</span> "RAC rate cell" means a cell in one of the rates tables in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(4)" title="">Regulation .19B(4) of this chapter</a> to which an MCO's enrollees are assigned pursuant to Regulation .19B(1)(a) and (2)(a) of this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(e)">(e)</span> "Rate adjustment period" means a 6-month period within the rate year that includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(e)(i)">(i)</span> The initial rate adjustment period beginning January 1 of the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(e)(ii)">(ii)</span> The mid-year rate adjustment period beginning July 1 of the rate year.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(f)">(f)</span> "Rate year" means the calendar year to which the rates calculated pursuant to this regulation apply.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(g)">(g)</span> "Risk Adjustment Category (RAC)" means a grouping of adjusted clinical groups (ACGs), each of which is associated with a similar level of risk.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)">(h)</span> "Risk assessment cohort" means each of the eight groupings of enrollees, assigned on the basis of their:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)(i)">(i)</span> Program eligibility category, either "families and children", as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(1)" title="">Regulation .19B(1) of this chapter</a>, or "disabled", as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19#B(2)" title="">Regulation .19B(2) of this chapter</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)(ii)">(ii)</span> Region of residence category, either in "Baltimore City" or in the "rest of State"; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(h)(iii)">(iii)</span> Age category, either at least 1 year old but younger than 21 years old, or 21 years old or older.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#A(2)(i)">(i)</span> "Risk assessment year" means the calendar year 2 years before the rate year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B">B.</span> For calculating an adjustment to MCO payment rates reflecting the relative level of risk of providing enrollees assigned to demographic rate cells covered health care services pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06" title="Chapter 06 Maryland Medicaid Managed Care Program: Benefits">COMAR 10.67.06</a>, the Department shall, for each MCO, identify the enrollees to be considered as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)">(1)</span> For each rate adjustment period in the rate year, identify the current demographic enrollees for each MCO who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)">(a)</span> In the risk assessment year:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)(i)">(i)</span> Were certified eligible for the Program for at least 6 months;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)(ii)">(ii)</span> Were assigned to a demographic rate cell; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(a)(iii)">(iii)</span> As of June 30, were 1 year old or older; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)">(b)</span> In the calendar year before the rate year:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)(i)">(i)</span> For the initial rate adjustment period calculation for the rate year 2004, were enrolled in the MCO in March;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)(ii)">(ii)</span> For the initial rate adjustment period calculation for rate years after 2004, were enrolled in the MCO in June; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(1)(b)(iii)">(iii)</span> For the mid-year rate adjustment period calculation, were enrolled in the MCO in December;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(2)">(2)</span> Assign each enrollee identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(1)" title="">§B(1) of this regulation</a> into one of the eight risk assessment cohorts;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)">(3)</span> Make the determinations necessary for the assignments required by <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(2)" title="">§B(2) of this regulation</a> consistent with the following time frames:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(a)">(a)</span> For an initial rate adjustment period calculation for the rate year 2004:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(a)(i)">(i)</span> An enrollee's eligibility category and region of residence as of March of the calendar year before the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(a)(ii)">(ii)</span> An enrollee's age category as of March 31 of the calendar year before the rate year;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(b)">(b)</span> For an initial rate adjustment period calculation for rate years after 2004:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(b)(i)">(i)</span> An enrollee's eligibility category and region of residence as of June of the calendar year before the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(b)(ii)">(ii)</span> An enrollee's age category as of June 30 of the calendar year before the rate year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(c)">(c)</span> For a mid-year rate adjustment period calculation:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(c)(i)">(i)</span> An enrollee's eligibility category and region of residence as of December of the calendar year before the rate year; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(3)(c)(ii)">(ii)</span> An enrollee's age category as of December 31 of the calendar year before the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#B(4)">(4)</span> For calculating an MCO's case mix adjustment pursuant to this regulation, disregard any risk assessment cohorts to which fewer than 50 of an MCO's enrollees are assigned pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(2)" title="">§B(2) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C">C.</span> Methodology for Determining MCO-specific RAC Case Mix Measures. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(1)">(1)</span> Based on encounter and fee-for-service data documenting services delivered during the risk assessment year, determine the diagnoses attributable to an MCO's enrollees identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(2)">(2)</span> Based on diagnoses in the risk assessment year, assign each enrollee identified pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a> to the appropriate risk adjustment category (RAC), consistent with the protocol set forth in Regulation .19B(1)(a) and (2)(a) of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(3)">(3)</span> Apply the RAC rates for the appropriate rate adjustment period to the RAC distribution determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C(2)" title="">§C(2) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(4)">(4)</span> Using the results of the calculations specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C(3)" title="">§C(3) of this regulation</a>, calculate an MCO's average RAC rates separately for each of the MCO's risk assessment cohorts derived in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#C(5)">(5)</span> To determine an MCO's relative RAC case mix factors, divide each of the MCO's average RAC rates determined in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C(4)" title="">§C(4) of this regulation</a> by each overall average RAC rate for all MCOs for the same risk assessment cohort.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D">D.</span> Methodology for Determining MCO-specific Demographic Case Mix Measures. For each MCO, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(1)">(1)</span> Determine the demographic distribution of its current enrollees as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(2)">(2)</span> Apply the appropriate demographic rates for the rate adjustment period to the demographic distribution as determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D(1)" title="">§D(1) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(3)">(3)</span> Using the results of the calculations specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D(2)" title="">§D(2) of this regulation</a>, calculate the MCO's average demographic rates separately for each of the MCO's risk assessment cohorts derived in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B" title="">§B of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#D(4)">(4)</span> To determine an MCO's relative demographic case mix factors, divide each of the MCO's average demographic rates determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D(3)" title="">§D(3) of this regulation</a> by each of the overall average of demographic rates for all MCOs for the same risk assessment cohort.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E">E.</span> MCO-Specific Case Mix Adjusted Demographic Rates. The Department shall, for each MCO:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(1)">(1)</span> Calculate MCO-specific risk adjustment factors by dividing, for each risk assessment cohort, the relative RAC case mix factor determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#C" title="">§C of this regulation</a>, by the relative demographic case mix factor determined pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#D" title="">§D of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(2)">(2)</span> Modify the MCO-specific risk adjustment factor derived for each risk assessment cohort pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(1)" title="">§E(1) of this regulation</a> as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(2)(a)">(a)</span> Reduce each risk adjustment factor that is higher than 1.1 to 1.1; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(2)(b)">(b)</span> Increase each risk adjustment factor that is lower than 0.9 to 0.9;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(3)">(3)</span> Subject to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(4)" title="">§E(4) of this regulation</a>, calculate the MCO-specific demographic rates for the rate adjustment period by multiplying the risk adjustment factor for each risk assessment cohort, derived pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(1)" title="">§E(1) of this regulation</a>, by the value specified in each demographic rate cell for the rate year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#E(4)">(4)</span> Apply a budget neutrality adjustment to the values derived in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E(3)" title="">§E(3) of this regulation</a> so that aggregate payments to all MCOs pursuant to this regulation are equivalent to the aggregate payments that would be due to all MCOs in the absence of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#F">F.</span> Case Mix Updates. The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#F(1)">(1)</span> Repeat the calculations described in §§C—E of this regulation every 6 months to update current MCO enrollees' region of residence, age, and enrollment categories as of the calendar year before the rate year, as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#B(3)" title="">§B(3) of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-3#F(2)">(2)</span> For the rate adjustment periods beginning January 1 and July 1 of each rate year, use each MCO's updated RAC case mix measures and updated demographic case mix measures to compute its demographic rates for the rate adjustment period, as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-3#E" title="">§E of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.19-4" data-order="|10|67|04|.19-4|" data-ref-path="10|67|04|.19-4" class="h__section">.19-4 MCO Medical Loss Ratio.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#A">A.</span> By September 1 of the second calendar year following the MLR reporting year, each MCO shall provide to the Department a completed MLR Reporting Template, including the MCO attestation and any additional documentation supporting the MLR reporting template.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#B">B.</span> The MLR experienced for each MCO in an MLR reporting year is the ratio of the numerator, as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D" title="">§D of this regulation</a>, to the denominator, as defined in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#E" title="">§E of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#C">C.</span> An MLR may be increased by a credibility adjustment, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#G" title="">§G of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D">D.</span> Components of MLR — Numerator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(1)">(1)</span> The numerator of an MCO's MLR for an MLR reporting year is the sum of the MCO's incurred claims, the MCO's expenditures for activities that improve health care quality, and fraud prevention activities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)">(2)</span> Incurred Claims. Incurred claims include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(a)">(a)</span> Direct claims that the MCO paid to providers, including under capitated contracts with network providers, for services or supplies covered under the contract and services meeting the requirements of 42 CFR §438.3(e) provided to enrollees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(b)">(b)</span> Unpaid claims liabilities for the MLR reporting year, including claims reported that are in the process of being adjusted or claims incurred but not reported;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(c)">(c)</span> Withholds from payments made to network providers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(d)">(d)</span> Claims that are recoverable for anticipated coordination of benefits;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(e)">(e)</span> Claims payments recoveries received because of subrogation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(f)">(f)</span> Incurred but not reported claims based on past experience, and modified to reflect current conditions, such as changes in exposure or claim frequency or severity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(g)">(g)</span> Changes in other claims-related reserves; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(2)(h)">(h)</span> Reserves for contingent benefits and the medical claim portion of lawsuits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(3)">(3)</span> An MCO shall deduct the following amounts from incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(3)(a)">(a)</span> Overpayment recoveries received from network providers; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(3)(b)">(b)</span> Prescription drug rebates received and accrued.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(4)">(4)</span> An MCO shall include the following expenditures in incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(4)(a)">(a)</span> The amount of incentive and bonus payments made, or expected to be made, to network providers; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(4)(b)">(b)</span> The amount of claims payments recovered through fraud reduction efforts, not to exceed the amount of fraud reduction expenses, and excluding activities specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D(3)" title="">§D(3) of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(5)">(5)</span> An MCO may include or deduct the following amounts from incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(5)(a)">(a)</span> Net payments; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(5)(b)">(b)</span> Receipts related to State-mandated solvency funds;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)">(6)</span> An MCO shall exclude the following amounts from incurred claims:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)(a)">(a)</span> Non-claims costs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)(b)">(b)</span> Amounts paid to the State as remittance under <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#I" title="">§I of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(6)(c)">(c)</span> Amounts paid to network providers under to 42 CFR §438.6(d).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)">(7)</span> Non-claims costs as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D(6)(a)" title="">§D(6)(a) of this regulation</a> include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(a)">(a)</span> Amounts paid to third-party vendors for secondary network savings;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(b)">(b)</span> Amounts paid to third-party vendors for network development, administrative fees, claims processing, and utilization management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(c)">(c)</span> Amounts paid, including amounts paid to a provider, for professional or administrative services that do not represent compensation or reimbursement for State plan services or services meeting the definition in 42 CFR §438.3(e) and provided to an enrollee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(7)(d)">(d)</span> Fines and penalties assessed by regulatory authorities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(8)">(8)</span> Incurred claims paid by one MCO that are later assumed by another MCO shall be reported by the assuming MCO for the entire MLR reporting year, and no incurred claims for that MLR reporting year may be reported by the ceding MCO.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)">(9)</span> An MCO shall include activities that improve health care quality in one of the following categories:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)(a)">(a)</span> An MCO activity that meets the requirements of 45 CFR §158.150(b) and is not excluded under 45 CFR §158.150(c);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)(b)">(b)</span> An MCO activity related to any EQR-related activity as described in 42 CFR §438.358(b) and (c); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(9)(c)">(c)</span> Any MCO expenditure that is related to Health Information Technology and meaningful use, meets the requirements placed on issuers found in 45 CFR §158.151, and is not considered incurred claims.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#D(10)">(10)</span> Excluding expenses for fraud reduction efforts in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#D(4)(b)" title="">§D(4)(b) of this regulation</a>, an MCO shall include expenditures on activities related to fraud prevention as adopted for the private market at 45 CFR part 158.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E">E.</span> Components of MLR  Denominator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(1)">(1)</span> The denominator of an MCO's MLR for an MLR reporting year shall equal the adjusted premium revenue. The adjusted premium revenue is the MCO's premium revenue minus the MCO's federal, State, and local taxes and licensing and regulatory fees and is aggregated in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)">(2)</span> Premium revenue includes the following for the MLR reporting year:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(a)">(a)</span> State capitation payments, developed in accordance with 42 CFR §438.4, to the MCO for all enrollees under a risk contract approved under 42 CFR §438.3(a), excluding payments made under 42 CFR §438.6(d);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(b)">(b)</span> State-developed, one-time payments, for specific life events of enrollees;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(c)">(c)</span> Other payments to the MCO approved under 42 CFR §438.6(b)(3);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(d)">(d)</span> Unpaid cost-sharing amounts that the MCO could have collected from enrollees under the contract, except those amounts the MCO can show it made a reasonable, but unsuccessful, effort to collect;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(e)">(e)</span> All changes to unearned premium reserves; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(2)(f)">(f)</span> Net payments or receipts related to risk sharing mechanisms developed in accordance with 42 CFR §438.5 or 42 CFR §438.6.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)">(3)</span> Federal, State, and Local Taxes and Licensing and Regulatory Fees. Taxes and licensing and regulatory fees for the MLR reporting year include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(a)">(a)</span> Statutory assessments to defray the operating expenses of any State or federal department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(b)">(b)</span> Examination fees in lieu of premium taxes as specified by State law;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(c)">(c)</span> Federal taxes and assessments allocated to MCOs excluding federal income taxes on investment income and capital gains and federal employment taxes;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)">(d)</span> State and local taxes and assessments including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(i)">(i)</span> Any industrywide (or subset) assessments, other than surcharges on specific claims, paid to the State or locality directly;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(ii)">(ii)</span> Guaranty fund assessments;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(iii)">(iii)</span> Assessments of State or locality industrial boards or other boards for operating expenses or for benefits to sick employed persons in connection with disability benefit laws or similar taxes levied by states;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(iv)">(iv)</span> State or locality income, excise, and business taxes other than premium taxes and State employment and similar taxes and assessments; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(d)(v)">(v)</span> State or locality premium taxes plus State or locality taxes based on reserves, if in lieu of premium taxes; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(e)">(e)</span> Payments made by an MCO that are otherwise exempt from federal income taxes, for community benefit expenditures as defined in 45 CFR §158.162(c), limited to the highest of either:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(e)(i)">(i)</span> 3 percent of earned premium; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(3)(e)(ii)">(ii)</span> The highest premium tax rate in the State for which the report is being submitted, multiplied by an MCO's earned premium in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#E(4)">(4)</span> The total amount of the denominator for an MCO, which is later assumed by another MCO, shall be reported by the assuming MCO for the entire MLR reporting year and no amount under this section for that year may be reported by the ceding MCO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F">F.</span> Allocation of Expense.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(1)">(1)</span> Each expense shall be included under only one type of expense, unless a portion of the expense fits under the definition of, or criteria for, one type of expense and the remainder fits into a different type of expense, in which case the MCO shall prorate the expense between types of expenses.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(2)">(2)</span> An MCO shall report on a pro-rata basis any expenditures that benefit multiple contracts or populations, or contracts other than those being reported.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)">(3)</span> Methods Used to Allocate Expenses.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)(a)">(a)</span> An MCO shall base allocation to each category on a generally accepted accounting method that is expected to yield the most accurate results.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)(b)">(b)</span> An MCO shall apportion shared expenses, including expenses under the terms of a management contract, pro rata to the contract incurring the expense.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#F(3)(c)">(c)</span> The reporting entity shall bear any expenses that relate solely to its operation and may not apportion its operating expenses to other entities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G">G.</span> Credibility Adjustment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(1)">(1)</span> An MCO may add a credibility adjustment to a calculated MLR if the MLR reporting year experience has partial credibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(2)">(2)</span> An MCO shall add the credibility adjustment to the reported MLR calculation before calculating any remittances if required by the State as described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.19-4#I" title="">§I of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(3)">(3)</span> An MCO may not add a credibility adjustment to a calculated MLR if the MLR reporting year experience has full credibility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(4)">(4)</span> If an MCO's experience has no credibility, it is presumed to meet or exceed the MLR calculation standards in this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#G(5)">(5)</span> MCOs shall use the base credibility factors CMS publishes on an annual basis that are developed according to the methodology in 42 CFR §438.8(h)(4).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H">H.</span> Eligibility Groups.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H(1)">(1)</span> MCOs shall aggregate data for all Medicaid eligibility groups covered under the contract with the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H(2)">(2)</span> MCOs shall report, and the Department shall calculate, an annual MLR as described in this regulation separately for the childless adult population.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#H(3)">(3)</span> The Department may require separate reporting and a separate MLR calculation for additional populations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#I">I.</span> An MCO shall provide a remittance for an MLR reporting year if the MLR for that MLR reporting year does not meet the minimum MLR standard of 85 percent.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#J">J.</span> Newly Contracted MCOs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#J(1)">(1)</span> The Department may exclude an MCO that is newly contracted with the State from the requirements in this section for the first year of the MCO's operation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#J(2)">(2)</span> Newly contracted MCOs shall comply with the requirements in this section during the next MLR reporting year in which the MCO is in business with the State, even if the first year was not a full 12 months.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#K">K.</span> If the Department makes a retroactive change to the capitation payments for an MLR reporting year where the report has already been submitted to the Department, the MCO shall recalculate the MLR for all MLR reporting years affected by the change and submit a new report.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#L">L.</span> MCOs shall attest to the accuracy of the calculation of the MLR in accordance with requirements of this section when submitting its report to the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#M">M.</span> MCOs shall report fraud prevention activities as required by 42 CFR §438.8.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#N">N.</span> Notice and Appeal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#N(1)">(1)</span> Within 30 days of its receipt of the notice of a remittance being due to the Department, an MCO may appeal the remittance as a sanction pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.10.02" title=".02 Appeal.">COMAR 10.67.10.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.19-4#N(2)">(2)</span> An MCO's appeal does not stay the obligation of the MCO to remit the amount owed to the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.20" data-order="|10|67|04|.20|" data-ref-path="10|67|04|.20" class="h__section">.20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A">A.</span> MCO Payment for Self-Referred Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)">(1)</span> For undisputed claims that are submitted to the MCO within 6 months of the date of service, an MCO shall reimburse out-of-plan providers within 30 days for eligible services performed upon an enrollee who has self-referred:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(a)">(a)</span> To a school-based health clinic pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#B" title="">COMAR 10.67.06.28B</a>, for services described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07" title="Chapter 07 Maryland Medicaid Managed Care Program: Program Integrity">COMAR 10.67.07</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(b)">(b)</span> For family planning services, pursuant to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#A" title="">COMAR 10.67.06.28A</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(c)">(c)</span> For an initial medical examination for an enrollee who is a child in State-supervised care, pursuant to <a class="internal-link " href="/us/md/exec/comar/10.67.04.13#F" title="">Regulation .13F of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(d)">(d)</span> For one annual diagnostic and evaluation service visit for an enrollee diagnosed with human immunodeficiency virus or acquired immune deficiency syndrome (HIV/AIDS) pursuant to COMAR 10.67.06.28E;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(e)">(e)</span> For obstetric and gynecologic care provided to a pregnant woman, under the circumstances described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28#C" title="">COMAR 10.67.06.28C</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(f)">(f)</span> For an initial medical examination of a newborn when the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(f)(i)">(i)</span> Examination is performed in a hospital by an on-call physician; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(1)(f)(ii)">(ii)</span> MCO failed to provide for the service before the newborn's discharge from the hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(2)">(2)</span> An MCO shall reimburse out-of-plan providers to whom enrollees have self-referred for school-based services as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.07.03" title=".03 Reporting.">COMAR 10.67.07.03</a> and family planning services including office visits (CPT codes 9920199205 and 9921199215), preventive medicine office visits (CPT codes 9938399386 and 9939399396), and all FDA-approved contraceptive devices, methods and supplies, at the established Medicaid rates.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(3)">(3)</span> An MCO shall reimburse out-of-plan providers to whom enrollees have self-referred for an initial examination for a child in State-supervised care utilizing the Medicaid payment schedule for the following procedure codes:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th>CPT code</th>
                        <th>Service Description</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <th>Initial Comprehensive Preventive Medicine (New Patient)</th>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99381</td>
                        <td data-vertical-align="middle">Infant (younger than 1 year old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99382</td>
                        <td data-vertical-align="middle">Early childhood (1—4 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99383</td>
                        <td data-vertical-align="middle">Late childhood (5—11 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99384</td>
                        <td data-vertical-align="middle">Adolescent (12—17 years old)</td>
                      </tr>
                      <tr>
                        <th>Periodic Comprehensive or Preventive Services (Established Patient)</th>
                        <td/>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99391</td>
                        <td data-vertical-align="middle">Infant (younger than 1 year old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99392</td>
                        <td data-vertical-align="middle">Early childhood (1—4 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99393</td>
                        <td data-vertical-align="middle">Late childhood (5—11 years old)</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">99394</td>
                        <td data-vertical-align="middle">Adolescent (12—17 years old)</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(4)">(4)</span> An MCO shall reimburse out-of-plan providers rendering pregnancy-related services, as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a>, at the Medicaid rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(5)">(5)</span> An MCO shall reimburse out-of-plan providers performing the DES for HIV/AIDS at the Medicaid rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(6)">(6)</span> An MCO may require enrollees to utilize in-plan providers for pharmacy and laboratory services ordered by out-of-plan providers of self-referral services, except as provided in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#A(7)" title="">§A(7) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(7)">(7)</span> An MCO shall reimburse out-of-plan providers at the Medicaid rate for medically necessary pharmacy and laboratory services when the pharmacy or laboratory service is provided:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(7)(a)">(a)</span> In connection with a self-referred service specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#A(1)" title="">§A(1) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(7)(b)">(b)</span> On-site by the out-of-plan provider at the same location that the self-referred service specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#A(1)" title="">§A(1) of this regulation</a> was delivered to the MCO's enrollee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(8)">(8)</span> An MCO shall reimburse out-of-plan providers for renal dialysis services in a Medicare-certified facility, at least the Medicaid rate, regardless of whether or not the MCO's preauthorization was secured.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(9)">(9)</span> An MCO shall reimburse out-of-plan providers under the circumstances described in COMAR 10.67.06.28G at a rate not less than the fee-for-service Medicaid rate for an initial medical examination of a newborn when the mother's MCO fails to provide for the service before the newborn is discharged from the hospital.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(10)">(10)</span> An MCO shall reimburse out-of-plan providers at the Medicaid fee-for-service rate for services performed in a free-standing birth center as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#A(11)">(11)</span> An MCO shall reimburse out-of-plan doulas at the Medicaid fee-for-service rate for services performed during the prenatal, labor and delivery, and postpartum periods of pregnancy as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.06.28" title=".28 Benefits — Self-Referral Services.">COMAR 10.67.06.28</a> through December 31, 2025.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B">B.</span> MCO Payment for Emergency Services Provided at a Hospital. An MCO shall reimburse a hospital emergency facility and provider, which is not required to obtain prior authorization or approval for payment from an MCO in order to obtain reimbursement under this regulation, for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(1)">(1)</span> Health care services that meet the definition of emergency services in Health-General Article, §19-701, Annotated Code of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(2)">(2)</span> Medical screening services rendered to meet the requirements of the federal Emergency Medical Treatment and Active Labor Act;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(3)">(3)</span> Medically necessary services if the MCO authorized, referred, or otherwise instructed the enrollee to use the emergency facility and the medically necessary services are related to the emergency condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#B(4)">(4)</span> Medically necessary services that relate to the condition presented and that are provided by the provider in the emergency facility to the enrollee if the MCO fails to provide 24-hour access to a physician.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C">C.</span> MCO Payment to an Out-of-Network Federally Qualified Health Center for Services Immediately Required Due to an Unforeseen Illness, Injury, or Condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)">(1)</span> Effective October 1, 2010, an MCO shall reimburse an out-of-network federally qualified health center (FQHC) for services provided to an enrollee that are immediately required due to an unforeseen illness, injury, or condition if:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(a)">(a)</span> The FQHC participates in the Medical Assistance Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(b)">(b)</span> The FQHC does not have a contract with the MCO;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(c)">(c)</span> The services are immediately required due to the enrollee's unforeseen illness, injury, or condition;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(d)">(d)</span> The emergent services are provided on site at the FQHC; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(1)(e)">(e)</span> The FQHC has, before rendering services, verified with the enrollee's primary care provider that the enrollee cannot be seen within a reasonable amount of time based on the severity of the enrollee's condition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(2)">(2)</span> An MCO may require that the FQHC provide documentation that the FQHC has obtained the verification required under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C(1)(e)" title="">§C(1)(e) of this regulation</a>. An MCO is not required to reimburse an out-of-network FQHC for emergent services provided to an enrollee if the FQHC fails to provide the documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(3)">(3)</span> An MCO may require that the FQHC provide documentation that services were required for the reasons identified under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C(1)(c)" title="">§C(1)(c) of this regulation</a>. An MCO is not required to reimburse an out-of-network FQHC for emergent services provided to an enrollee if the FQHC fails to provide the documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(4)">(4)</span> The rate at which the MCO shall reimburse an out-of-network FQHC for services provided under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C(1)" title="">§C(1) of this regulation</a> shall be the rate identified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">COMAR 10.67.04.21</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#C(5)">(5)</span> For any reimbursement paid by an MCO under <a class="internal-link " href="/us/md/exec/comar/10.67.04.20#C" title="">§C of this regulation</a>, the Program shall pay the MCO the difference between the rates identified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.04.21" title=".21 Payments to Federally Qualified Health Centers (FQHC).">COMAR 10.67.04.21</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08.05" title=".05 Federally Qualified Health Center Services.">COMAR 10.09.08.05</a>-1.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D">D.</span> MCO Payment for Provider Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D(1)">(1)</span> An MCO shall pass on to providers any MCO rate adjustment that is specified by the Department for a fee increase.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D(2)">(2)</span> For inpatient services performed in hospitals, an MCO shall pay all providers, regardless of the provider's contracting status, at least the Medicaid fee-for-service rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#D(3)">(3)</span> The MCO may not be required to pay providers more than the Medicaid fee-for-service rate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E">E.</span> Payment for Hospital Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E(1)">(1)</span> An MCO shall reimburse Maryland hospital providers on the basis of rates approved by the Maryland Health Services Cost Review Commission (HSCRC).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E(2)">(2)</span> An MCO shall reimburse hospital administrative days at the Medicaid fee-for-service rate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.20#E(3)">(3)</span> Upon the direction of the Department, an MCO shall reduce payments by 20 percent to a hospital located in a contiguous state or in the District of Columbia for services rendered to its enrollees, if the hospital has failed to supply appropriate discharge data to the Health Services Cost Review Commission.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.21" data-order="|10|67|04|.21|" data-ref-path="10|67|04|.21" class="h__section">.21 Payments to Federally Qualified Health Centers (FQHC).</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A">A.</span> FQHC’s shall be reimbursed under the Alternative Payment System (APS).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(1)">(1)</span> The Department shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(1)(a)">(a)</span> Pay the MCO a prospective payment based on encounter data; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(1)(b)">(b)</span> Reconcile the prospective amount paid to the MCO with the MCO's actual expenditure amount, after receipt of MCO encounter data; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#A(2)">(2)</span> MCOs shall reimburse any contracted FQHC, the FQHC’s rate established in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08.05" title=".05 Federally Qualified Health Center Services.">COMAR 10.09.08.05</a>-1A.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.21#B">B.</span> For self-referred services described in <a class="internal-link " href="/us/md/exec/comar/10.67.04.20" title=".20 MCO Payment for Self-Referred, Emergency, Physician, and Hospital Services.">Regulation .20 of this chapter</a>, the MCO shall pay the FQHC’s usual rate in accordance with <a class="internal-link " href="/us/md/exec/comar/10.67.04.21#A" title="">§A of this regulation</a>, regardless of the FQHC’s contracted status with the MCO.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.22" data-order="|10|67|04|.22|" data-ref-path="10|67|04|.22" class="h__section">.22 Stop Loss Program.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A">A.</span> An MCO shall qualify for protection under the Stop Loss Program if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A(1)">(1)</span> It was participating in HealthChoice as of April 1, 1999;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A(2)">(2)</span> It was unable to self-insure or obtain a contract with another entity for Stop Loss reinsurance after July 1, 1999; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#A(3)">(3)</span> By July 1, 1999, the MCO requested the Department to continue to provide Stop Loss Protection at a rate determined by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#B">B.</span> An MCO shall notify the Department that the acute inpatient hospital costs of an enrollee are expected to exceed the Stop Loss limit as soon as it knows that this is likely to occur.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#C">C.</span> Upon confirming eligibility for stop loss protection, the Department shall assume liability for reimbursement of 90 percent of accrued acute inpatient hospital charges according to established Medicaid fee-for-service rates for medically necessary acute inpatient treatment rendered to the enrollee above the stop loss limit throughout the remainder of the calendar year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#D">D.</span> An MCO shall remain financially liable for reimbursing 10 percent of accrued acute inpatient hospital charges for medically necessary treatment rendered to the enrollee above the stop loss limit throughout the remainder of the calendar year, and shall maintain full responsibility for the provision of health care services to the enrollee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#E">E.</span> At the beginning of the next calendar year, an MCO shall reassume full financial responsibility and full discretion for developing medical treatment plans for any enrollee who qualified for the Stop Loss Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#F">F.</span> The Department's Extended Stop Loss Period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#F(1)">(1)</span> If an inpatient enrollee remains hospitalized at the end of a calendar year and incurs acute hospital costs that exceed the Stop Loss limit into the following calendar year without interruption, the Department's stop loss period shall be extended until the end of that hospitalization.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#F(2)">(2)</span> The MCO shall remain financially liable for costs up to the Stop Loss limit for enrollees who remain hospitalized in an acute setting at the end of the calendar year as specified in §§A and D of this regulation until the enrollee is discharged.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#G">G.</span> For calendar year 2001 and beyond, the MCO shall submit the MCO's Stop Loss Reinsurance Plan or Self-Insurance Plan to the Maryland Insurance Administration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#H">H.</span> If an MCO chooses to have the Department provide its Stop Loss coverage, an adjustment will be made to the capitation amount the MCO is paid.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.22#I">I.</span> Upon the termination of the provider agreement between the enrollee's MCO and the Department, if an MCO has failed to fulfill its financial liability under this regulation, the Department shall assume responsibility only for costs that exceed the Stop Loss limit as specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.22#C" title="">§C of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.23" data-order="|10|67|04|.23|" data-ref-path="10|67|04|.23" class="h__section">.23 Marketing.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#A">A.</span> An MCO may not have face-to-face or telephone contact with a recipient, or otherwise solicit a recipient who is not an enrollee of the MCO, unless authorized by the Department or the recipient initiates the contact.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B">B.</span> Subject to prior approval by the Department, an MCO may engage in marketing activities designed to make recipients aware of their availability, as well as any special services they offer. Unless they involve face-to-face solicitation, these marketing activities may involve campaigns using but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(1)">(1)</span> Television;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(2)">(2)</span> Radio;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(3)">(3)</span> Newspaper;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(4)">(4)</span> Informational booths at public events;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(5)">(5)</span> Billboards and other public displays;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(6)">(6)</span> Addressee-blind informational mailings, but only when mailed to the MCO's entire service area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(7)">(7)</span> Magazines;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(8)">(8)</span> Airborne marketing displays; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#B(9)">(9)</span> Public conveyances.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C">C.</span> An MCO may not engage in any cold call marketing, including activities using or involving any of the following mechanisms:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(1)">(1)</span> Direct marketing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(2)">(2)</span> Telephone solicitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(3)">(3)</span> Door to door flyers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(4)">(4)</span> Email;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(5)">(5)</span> Texting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(6)">(6)</span> Material or financial incentives of any kind, with the exception of advertising trinkets such as balloons or pens that have an acquisition cost of $5 or less; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#C(7)">(7)</span> Influencing enrollment in conjunction with the sale or offer of private insurance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D">D.</span> Standards for Departmental Approval of MCO Advertising.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)">(1)</span> MCO advertising shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(a)">(a)</span> Be based on documented fact;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(b)">(b)</span> Identify all telephone numbers used that do not belong to the MCOs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(c)">(c)</span> Include the statement, "'HealthChoice' is a program of the Maryland Department of Health"; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(1)(d)">(d)</span> Be at a fifth grade reading level.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)">(2)</span> MCO advertising may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(a)">(a)</span> Be false or misleading;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(b)">(b)</span> Ascribe to the MCO unique coverage or services that are otherwise required by State or federal law or regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(c)">(c)</span> Assert that a recipient shall enroll in the MCO in order to obtain benefits or in order not to lose benefits; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.67.04.23#D(2)(d)">(d)</span> Assert that the MCO is endorsed by CMS, the federal or State government or similar entity.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.24" data-order="|10|67|04|.24|" data-ref-path="10|67|04|.24" class="h__section">.24 Repealed.</h2>
                <h2 id="/us/md/exec/comar/10.67.04.25" data-order="|10|67|04|.25|" data-ref-path="10|67|04|.25" class="h__section">.25 Enrollee Outreach Plan.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#A">A.</span> An MCO shall submit to the Department, on an annual basis, a written enrollee outreach plan that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#A(1)">(1)</span> Describes how the MCO intends to comply, in the upcoming year, with the outreach requirements of Health-General Article, §15-103(b)(9), Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#A(2)">(2)</span> Provides evidence of the MCO's compliance during the previous year, with the outreach requirements of Health-General Article, §15-103(b)(9), Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B">B.</span> Submission Date.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B(1)">(1)</span> An MCO applicant shall submit its initial enrollee outreach plan, as part of its MCO application, as required by COMAR 10.09.64.06O.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B(2)">(2)</span> An MCO shall submit by December 1 an enrollee outreach plan, including the information specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.25#A" title="">§A of this regulation</a>, to be reviewed as part of the triennial audit performed by an external quality review organization (EQRO).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.25#B(3)">(3)</span> For years in which the triennial EQRO audit is not performed, an MCO shall submit by April 30 any changes to the enrollee outreach plan, including the information specified in <a class="internal-link " href="/us/md/exec/comar/10.67.04.25#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.26" data-order="|10|67|04|.26|" data-ref-path="10|67|04|.26" class="h__section">.26 Time Period for Termination of Provider Agreement.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#A">A.</span> An MCO may terminate its provider agreement with the State as provided in §§B—D of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#B">B.</span> The MCO shall provide written notification to the Department of the MCO's intent to terminate the MCO's provider agreement with the State for any given calendar year by the previous October 1.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#C">C.</span> An MCO that has previously terminated the provider agreement with the State and would like to sign a new agreement with the State, shall follow the application process as specified under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.03" title="Chapter 03 Maryland Medicaid Managed Care Program: MCO Application">COMAR 10.67.03</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.26#D">D.</span> The Department may waive the requirement under <a class="internal-link " href="/us/md/exec/comar/10.67.04.26#B" title="">§B of this regulation</a> if the Department determines that the circumstances warrant, including but not limited to a reduction in rates outside the normal rate setting process or an MCO exit from the program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.67.04.27" data-order="|10|67|04|.27|" data-ref-path="10|67|04|.27" class="h__section">.27 Newborn Coordinator.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#A">A.</span> An MCO shall identify a newborn coordinator who shall be available to providers during the MCO's business hours as a contact for concerns related to eligibility and provision of services to newborns.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#B">B.</span> The newborn coordinator shall provide services for a newborn:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#B(1)">(1)</span> Whose mother is enrolled in the MCO on the date of the newborn's birth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#B(2)">(2)</span> Who is enrolled or who is autoassigned to the MCO after birth.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C">C.</span> The newborn coordinator shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(1)">(1)</span> Research and confirm the assignment of an eligible newborn to a managed care organization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(2)">(2)</span> Interface with the enrollment agent, the Department, the newborn coordinators of other MCOs, and the provider to resolve any eligibility issues involving multiple MCOs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(3)">(3)</span> Facilitate and confirm the selection of a primary care provider for an eligible newborn;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(4)">(4)</span> Request an MCO ID card for a newborn when necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(5)">(5)</span> Make retroactive PCP enrollments when necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(6)">(6)</span> Facilitate the resolution of claims for services provided to an eligible newborn;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(7)">(7)</span> Provide general guidance to providers and their office staff on newborn-related issues;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(8)">(8)</span> Coordinate with ancillary care providers to facilitate appropriate delivery of care and payment of claims; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.67.04.27#C(9)">(9)</span> Coordinate and authorize in-network care when the newborn does not yet appear in EVS or the MCO's system, or out-of-network care when the MCO cannot offer an appropriate in-network provider.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.67.03" aria-label="Chapter 03 Maryland Medicaid Managed Care Program: MCO Application">
                <div class="h__ui">Previous</div>
                <span>Chapter 03 Maryland Medicaid Managed Care Program: MCO Application</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.67.05" aria-label="Chapter 05 Maryland Medicaid Managed Care Program: Access">
                <div class="h__ui">Next</div>
                <span>Chapter 05 Maryland Medicaid Managed Care Program: Access</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
